Vitamin D and autoimmune disease

Vitamin D: Oxidative Stress, Immunity, and Aging

Volumn , Issue , 2012, Pages 239-306

  Hayes, Colleen E ^a   Nelson, Corwin D ^a   Spanier, Justin A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84979784763     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13714     Document Type: Chapter

References (546)

1. Blumberg, R. S., B. Dittel, D. Hafler, M. von Herrath, and F. O. Nestle. 2012. Unraveling the autoimmune translational research process layer by layer. Nature Medicine 18:35-41.
2. Prosser, D. E., and G. Jones. 2004. Enzymes involved in the activation and inactivation of vitamin D. Trends in Biochemical Sciences 29:664-673.
3. Verstuyf, A., G. Carmeliet, R. Bouillon, and C. Mathieu. 2010. Vitamin D: A pleiotropic hormone. Kidney International 78:140-145.
4. Holick, M. F., T. C. Chen, Z. Lu, and E. Sauter. 2007. Vitamin D and skin physiology: A D-lightful story. Journal of Bone and Mineral Research 22 Suppl 2:V28-33.
5. Zerwekh, J. E. 2008. Blood biomarkers of vitamin D status. The American Journal of Clinical Nutrition 87:1087S-1091S.
6. Holick, M. F. 2010. Vitamin D: Extraskeletal health. Endocrinology and Metabolism Clinics of North America 39:381-400.
7. Adams, J. S., H. Chen, R. Chun, S. Ren, S. Wu, M. Gacad, L. Nguyen, J. Ride, P. Liu, R. Modlin, and M. Hewison. 2007. Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: The human innate immune response. Journal of Bone and Mineral Research 22 Suppl 2:V20-24.
8. Spach, K. M., and C. E. Hayes. 2005. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. Journal of Immunology 175:4119-4126.
9. Hewison, M., F. Burke, K. N. Evans, D. A. Lammas, D. M. Sansom, P. Liu, R. L. Modlin, and J. S. Adams. 2007. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. The Journal of Steroid Biochemistry and Molecular Biology 103:316-321.
10. Chun, R. F., A. L. Lauridsen, L. Suon, L. A. Zella, J. W. Pike, R. L. Modlin, A. R. Martineau, R. J. Wilkinson, J. Adams, and M. Hewison. 2010. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. The Journal of Clinical Endocrinology and Metabolism 95:3368-3376.
11. Ahn, J., K. Yu, R. Stolzenberg-Solomon, K. C. Simon, M. L. McCullough, L. Gallicchio, E. J. Jacobs, A. Ascherio, K. Helzlsouer, K. B. Jacobs, Q. Li, S. J. Weinstein, M. Purdue, J. Virtamo, R. Horst, W. Wheeler, S. Chanock, D. J. Hunter, R. B. Hayes, P. Kraft, and D. Albanes. 2010. Genome-wide association study of circulating vitamin D levels. Human Molecular Genetics 19:2739-2745.
12. Adams, J. S., and M. Hewison. 2010. Update in vitamin D. The Journal of Clinical Endocrinology and Metabolism 95:471-478.
13. Holick, M. F. 2008. The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Molecular Aspects of Medicine 29:361-368.
14. Hayes, C. E., F. E. Nashold, C. G. Mayne, J. A. Spanier, and C. D. Nelson. 2011. Vitamin D and multiple sclerosis. In Vitamin D, edited by D. Feldman, J. W. Pike, and J. S. Adams, 3rd ed., 1843-1877. Elsevier, San Diego, CA.
15. Lips, P., M. C. Chapuy, B. Dawson-Hughes, H. A. Pols, and M. F. Holick. 1999. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporosis International 9:394-397.
16. Hollis, B. W. 2008. Measuring 25-hydroxyvitamin D in a clinical environment: Challenges and needs. The American Journal of Clinical Nutrition 88:507S-510S.
17. Holick, M. F. 2003. Vitamin D: A millennium perspective. Journal of Cellular Biochemistry 88:296-307.
18. Clemens, T. L., J. S. Adams, S. L. Henderson, and M. F. Holick. 1982. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1:74-76.
19. Bell, N. H., A. Greene, S. Epstein, M. J. Oexmann, S. Shaw, and J. Shary. 1985. Evidence for alteration of the vitamin D-endocrine system in blacks. Journal of Clinical Investigation 76:470-473.
20. Bell, N. H. 1997. Bone and mineral metabolism in African Americans. Trends in Endocrinology and Metabolism 8:240-245.
21. Chen, T. C., F. Chimeh, Z. Lu, J. Mathieu, K. S. Person, A. Zhang, N. Kohn, S. Martinello, R. Berkowitz, and M. F. Holick. 2007. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Archives of Biochemistry and Biophysics 460:213-217.
22. Orton, S. M., A. P. Morris, B. M. Herrera, S. V. Ramagopalan, M. R. Lincoln, M. J. Chao, R. Vieth, A. D. Sadovnick, and G. C. Ebers. 2008. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. The American Journal of Clinical Nutrition 88:441-447.
23. Fu, L., F. Yun, M. Oczak, B. Y. Wong, R. Vieth, and D. E. Cole. 2009. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clinical Biochemistry 42:1174-1177.
24. Pike, J. W., and M. B. Meyer. 2010. The vitamin D receptor: New paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinology and Metabolism Clinics of North America 39:255-269.
25. Toell, A., P. Polly, and C. Carlberg. 2000. All natural DR3-type vitamin D response elements show a similar functionality in vitro. The Biochemical Journal 352 (Pt 2):301-309.
26. Brennan, A., D. R. Katz, J. D. Nunn, S. Barker, M. Hewison, L. J. Fraher, and J. L. O’Riordan. 1987. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 61:457-461.
27. Veldman, C. M., M. T. Cantorna, and H. F. DeLuca. 2000. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Archives of Biochemistry and Biophysics 374:334-338.
28. Nashold, F. E., K. A. Hoag, J. Goverman, and C. E. Hayes. 2001. Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 119:16-29.
29. Chang, S. H., Y. Chung, and C. Dong. 2010. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. The Journal of Biological Chemistry 285:38751-38755.
30. Mayne, C. G., J. A. Spanier, L. M. Relland, C. B. Williams, and C. E. Hayes. 2011. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. European Journal of Immunology 41:822-832.
31. Hauser, S. L., and J. R. Oksenberg. 2006. The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron 52:61-76.
32. Dutta, R., and B. D. Trapp. 2011. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Progress in Neurobiology 93:1-12.
33. Scalfari, A., A. Neuhaus, A. Degenhardt, G. P. Rice, P. A. Muraro, M. Daumer, and G. C. Ebers. 2010. The natural history of multiple sclerosis-A geographically based study 10: Relapses and long-term disability. Brain 133:1914-1929.
34. Koch, M., E. Kingwell, P. Rieckmann, and H. Tremlett. 2010. The natural history of secondary progressive multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 81:1039-1043.
35. Ramagopalan, S. V., J. K. Byrnes, S. M. Orton, D. A. Dyment, C. Guimond, I. M. Yee, G. C. Ebers, and A. D. Sadovnick. 2010. Sex ratio of multiple sclerosis and clinical phenotype. European Journal of Neurology 17:634-637.
36. Ramagopalan, S. V., and G. C. Ebers. 2009. Multiple sclerosis: Major histocompatibility complexity and antigen presentation. Genome Medicine 1:105.
37. Watson, C. T., A. E. Para, M. R. Lincoln, S. V. Ramagopalan, S. M. Orton, K. M. Morrison, L. Handunnetthi, A. E. Handel, M. J. Chao, J. Morahan, A. D. Sadovnick, F. Breden, and G. C. Ebers. 2011. Revisiting the T-cell receptor alpha/delta locus and possible associations with multiple sclerosis. Genes and Immunity 12:59-66.
38. Steinman, L., and S. S. Zamvil. 2006. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Annals of Neurology 60:12-21.
39. Baxter, A. G. 2007. The origin and application of experimental autoimmune encephalomyelitis. Nature Reviews. Immunology 7:904-912.
40. Ramagopalan, S. V., R. Dobson, U. C. Meier, and G. Giovannoni. 2010. Multiple sclerosis: Risk factors, prodromes, and potential causal pathways. Lancet Neurology 9:727-739.
41. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nature Reviews. Immunology 9:393-407.
42. Oksenberg, J. R., and S. E. Baranzini. 2010. Multiple sclerosis genetics-is the glass half full, or half empty? Nature Reviews. Neurology 6:429-437.
43. Lincoln, M. R., S. V. Ramagopalan, M. J. Chao, B. M. Herrera, G. C. Deluca, S. M. Orton, D. A. Dyment, A. D. Sadovnick, and G. C. Ebers. 2009. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proceedings of the National Academy of Sciences of the United States of America 106:7542-7547.
44. De Jager, P. L., L. B. Chibnik, J. Cui, J. Reischl, S. Lehr, K. C. Simon, C. Aubin, D. Bauer, J. F. Heubach, R. Sandbrink, M. Tyblova, P. Lelkova, E. Havrdova, C. Pohl, D. Horakova, A. Ascherio, D. A. Hafler, and E. W. Karlson. 2009. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: A weighted genetic risk score. Lancet Neurology 8:1111-1119.
45. Sawcer, S., G. Hellenthal, M. Pirinen, C. C. Spencer, N. A. Patsopoulos, L. Moutsianas, A. Dilthey, Z. Su, C. Freeman, S. E. Hunt, S. Edkins, E. Gray, D. R. Booth, S. C. Potter, A. Goris, G. Band, A. B. Oturai, A. Strange, J. Saarela, C. Bellenguez, B. Fontaine, M. Gillman, B. Hemmer, R. Gwilliam, F. Zipp, A. Jayakumar, R. Martin, S. Leslie, S. Hawkins, E. Giannoulatou, S. D’Alfonso, H. Blackburn, F. M. Boneschi, J. Liddle, H. F. Harbo, M. L. Perez, A. Spurkland, M. J. Waller, M. P. Mycko, M. Ricketts, M. Comabella, N. Hammond, I. Kockum, O. T. McCann, M. Ban, P. Whittaker, A. Kemppinen, P. Weston, C. Hawkins, S. Widaa, J. Zajicek, S. Dronov, N. Robertson, S. J. Bumpstead, L. F. Barcellos, R. Ravindrarajah, R. Abraham, L. Alfredsson, K. Ardlie, C. Aubin, A. Baker, K. Baker, S. E. Baranzini, L. Bergamaschi, R. Bergamaschi, A. Bernstein, A. Berthele, M. Boggild, J. P. Bradfield, D. Brassat, S. A. Broadley, D. Buck, H. Butzkueven, R. Capra, W. M. Carroll, P. Cavalla, E. G. Celius, S. Cepok, R. Chiavacci, F. Clerget-Darpoux, K. Clysters, G. Comi, M. Cossburn, I. Cournu-Rebeix, M. B. Cox, W. Cozen, B. A. Cree, A. H. Cross, D. Cusi, M. J. Daly, E. Davis, P. I. de Bakker, M. Debouverie, M. B. D’Hooghe, K. Dixon, R. Dobosi, B. Dubois, D. Ellinghaus, I. Elovaara, F. Esposito, C. Fontenille, S. Foote, A. Franke, D. Galimberti, A. Ghezzi, J. Glessner, R. Gomez, O. Gout, C. Graham, S. F. Grant, F. R. Guerini, H. Hakonarson, P. Hall, A. Hamsten, H. P. Hartung, R. N. Heard, S. Heath, J. Hobart, M. Hoshi, C. Infante-Duarte, G. Ingram, W. Ingram, T. Islam, M. Jagodic, M. Kabesch, A. G. Kermode, T. J. Kilpatrick, C. Kim, N. Klopp, K. Koivisto, M. Larsson, M. Lathrop, J. S. Lechner-Scott, M. A. Leone, V. Leppa, U. Liljedahl, I. L. Bomfim, R. R. Lincoln, J. Link, J. Liu, A. R. Lorentzen, S. Lupoli, F. Macciardi, T. Mack, M. Marriott, V. Martinelli, D. Mason, J. L. McCauley, F. Mentch, I. L. Mero, T. Mihalova, X. Montalban, J. Mottershead, K. M. Myhr, P. Naldi, W. Ollier, A. Page, A. Palotie, J. Pelletier, L. Piccio, T. Pickersgill, F. Piehl, S. Pobywajlo, H. L. Quach, P. P. Ramsay, M. Reunanen, R. Reynolds, J. D. Rioux, M. Rodegher, S. Roesner, J. P. Rubio, I. M. Ruckert, M. Salvetti, E. Salvi, A. Santaniello, C. A. Schaefer, S. Schreiber, C. Schulze, R. J. Scott, F. Sellebjerg, K. W. Selmaj, D. Sexton, L. Shen, B. Simms-Acuna, S. Skidmore, P. M. Sleiman, C. Smestad, P. S. Sorensen, H. B. Sondergaard, J. Stankovich, R. C. Strange, A. M. Sulonen, E. Sundqvist, A. C. Syvanen, F. Taddeo, B. Taylor, J. M. Blackwell, P. Tienari, E. Bramon, A. Tourbah, M. A. Brown, E. Tronczynska, J. P. Casas, N. Tubridy, A. Corvin, J. Vickery, J. Jankowski, P. Villoslada, H. S. Markus, K. Wang, C. G. Mathew, J. Wason, C. N. Palmer, H. E. Wichmann, R. Plomin, E. Willoughby, A. Rautanen, J. Winkelmann, M. Wittig, R. C. Trembath, J. Yaouanq, A. C. Viswanathan, H. Zhang, N. W. Wood, R. Zuvich, P. Deloukas, C. Langford, A. Duncanson, J. R. Oksenberg, M. A. Pericak-Vance, J. L. Haines, T. Olsson, J. Hillert, A. J. Ivinson, P. L. De Jager, L. Peltonen, G. J. Stewart, D. A. Hafler, S. L. Hauser, G. McVean, P. Donnelly, and A. Compston. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214-219.
46. Baranzini, S. E., J. Mudge, J. C. van Velkinburgh, P. Khankhanian, I. Khrebtukova, N. A. Miller, L. Zhang, A. D. Farmer, C. J. Bell, R. W. Kim, G. D. May, J. E. Woodward, S. J. Caillier, J. P. McElroy, R. Gomez, M. J. Pando, L. E. Clendenen, E. E. Ganusova, F. D. Schilkey, T. Ramaraj, O. A. Khan, J. J. Huntley, S. Luo, P. Y. Kwok, T. D. Wu, G. P. Schroth, J. R. Oksenberg, S. L. Hauser, and S. F. Kingsmore. 2010. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464:1351-1356.
47. Burrell, A. M., A. E. Handel, S. V. Ramagopalan, G. C. Ebers, and J. M. Morahan. 2011. Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC). Discovery Medicine 11:187-196.
48. Ebers, G. C. 2008. Environmental factors and multiple sclerosis. Lancet Neurology 7:268-277.
49. Lauer, K. 2010. Environmental risk factors in multiple sclerosis. Expert Review of Neurotherapeutics 10:421-440.
50. Ebers, G. C., D. E. Bulman, A. D. Sadovnick, D. W. Paty, S. Warren, W. Hader, T. J. Murray, T. P. Seland, P. Duquette, T. Grey, et al. 1986. A population-based study of multiple sclerosis in twins. New England Journal of Medicine 315:1638-1642.
51. Simpson, S., Jr., L. Blizzard, P. Otahal, I. Van der Mei, and B. Taylor. 2011. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry 82:1132-1141.
52. McLeod, J. G., S. R. Hammond, and J. F. Kurtzke. 2011. Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: A reassessment-Part I: Risk of MS by age at immigration. Journal of Neurology 258:1140-1149.
53. Orton, S. M., S. V. Ramagopalan, D. Brocklebank, B. M. Herrera, D. A. Dyment, I. M. Yee, A. D. Sadovnick, and G. C. Ebers. 2010. Effect of immigration on multiple sclerosis sex ratio in Canada: The Canadian Collaborative Study. Journal of Neurology, Neurosurgery, and Psychiatry 81:31-36.
54. Goldberg, P. 1974. Multiple sclerosis: Vitamin D and calcium as environmental determinants of prevalence (a viewpoint)-Part 1: Sunlight, dietary factors and epidemiology. International Journal of Environmental Studies 6:19-27.
55. Craelius, W. 1978. Comparative epidemiology of multiple sclerosis and dental caries. Journal of Epidemiology and Community Health 32:155-165.
56. Schwartz, G. G. 1992. Multiple sclerosis and prostate cancer: What do their similar geographies suggest? Neuroepidemiology 11:244-254.
57. Hayes, C. E., M. T. Cantorna, and H. F. DeLuca. 1997. Vitamin D and multiple sclerosis. Proceedings of the Society for Experimental Biology and Medicine 216:21-27.
58. Cantorna, M. T., C. E. Hayes, and H. F. DeLuca. 1996. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 93:7861-7864.
59. Smolders, J., J. Damoiseaux, P. Menheere, and R. Hupperts. 2008. Vitamin D as an immune modulator in multiple sclerosis, a review. Journal of Neuroimmunology 194:7-17.
60. Ascherio, A., K. L. Munger, and K. C. Simon. 2010. Vitamin D and multiple sclerosis. Lancet Neurology 9:599-612.
61. Hanwell, H. E., and B. Banwell. 2011. Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochimica et Biophysica Acta 1812:202-212.
62. Correale, J., M. C. Ysrraelit, and M. I. Gaitan. 2011. Vitamin D-mediated immune regulation in multiple sclerosis. Journal of the Neurological Sciences 311:23-31.
63. Acheson, E. D., C. A. Bachrach, and F. M. Wright. 1960. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Psychiatrica Scandinavica 35 (Supplement 147):132-147.
64. Ebers, G. C., and A. D. Sadovnick. 1993. The geographic distribution of multiple sclerosis: A review. Neuroepidemiology 12:1-5.
65. Lonergan, R., K. Kinsella, P. Fitzpatrick, J. Brady, B. Murray, C. Dunne, R. Hagan, M. Duggan, S. Jordan, M. McKenna, M. Hutchinson, and N. Tubridy. 2011. Multiple sclerosis prevalence in Ireland: Relationship to vitamin D status and HLA genotype. Journal of Neurology, Neurosurgery, and Psychiatry 82:317-322.
66. Fernandes de Abreu, D. A., M. C. Babron, I. Rebeix, C. Fontenille, J. Yaouanq, D. Brassat, B. Fontaine, F. Clerget-Darpoux, F. Jehan, and F. Feron. 2009. Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 15:1146-1152.
67. Salzer, J., A. Svenningsson, and P. Sundstrom. 2010. Season of birth and multiple sclerosis in Sweden. Acta Neurologica Scandinavica 121:20-23.
68. Bayes, H. K., C. J. Weir, and C. O’Leary. 2010. Timing of birth and risk of multiple sclerosis in the Scottish population. European Neurology 63:36-40.
69. Willer, C. J., D. A. Dyment, A. D. Sadovnick, P. M. Rothwell, T. J. Murray, and G. C. Ebers. 2005. Timing of birth and risk of multiple sclerosis: Population-based study. British Medical Journal 330:120.
70. Sotgiu, S., M. Pugliatti, M. A. Sotgiu, M. L. Fois, G. Arru, A. Sanna, and G. Rosati. 2006. Seasonal fluctuation of multiple sclerosis births in Sardinia. Journal of Neurology 253:38-44.
71. Saastamoinen, K. P., M. K. Auvinen, and P. J. Tienari. 2012. Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland. Multiple Sclerosis (Houndmills, Basingstoke, England) 18:563-568.
72. Staples, J., A. L. Ponsonby, and L. Lim. 2010. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: Longitudinal analysis. British Medical Journal 340:c1640.
73. McDowell, T. Y., S. Amr, P. Langenberg, W. Royal, C. Bever, W. J. Culpepper, and D. D. Bradham. 2010. Time of birth, residential solar radiation and age at onset of multiple sclerosis. Neuroepidemiology 34:238-244.
74. Givon, U., G. Zeilig, M. Dolev, and A. Achiron. 2012. The month of birth and the incidence of multiple sclerosis in the israeli population. Neuroepidemiology 38:64-68.
75. Ebers, G. 2010. Month of birth and multiple sclerosis risk in Scotland. European Neurology 63:41-42.
76. Meier, D. S., K. E. Balashov, B. Healy, H. L. Weiner, and C. R. Guttmann. 2010. Seasonal prevalence of MS disease activity. Neurology 75:799-806.
77. Handel, A. E., G. Disanto, L. Jarvis, R. McLaughlin, A. Fries, G. C. Ebers, and S. V. Ramagopalan. 2011. Seasonality of admissions with multiple sclerosis in Scotland. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies 18:1109-1111.
78. Saaroni, H., A. Sigal, I. Lejbkowicz, and A. Miller. 2010. Mediterranean weather conditions and exacerbations of multiple sclerosis. Neuroepidemiology 35:142-151.
79. Damasceno, A., F. Von Glehn, L. de Deus-Silva, and B. P. Damasceno. 2012. Monthly variation of multiple sclerosis activity in the southern hemisphere: Analysis from 996 relapses in Brazil. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies 19:660-662.
80. Ascherio, A., and K. L. Munger. 2007. Environmental risk factors for multiple sclerosis-Part II: Noninfectious factors. Annals of Neurology 61:504-513.
81. Lucas, R. M., A. L. Ponsonby, K. Dear, P. C. Valery, M. P. Pender, B. V. Taylor, T. J. Kilpatrick, T. Dwyer, A. Coulthard, C. Chapman, I. van der Mei, D. Williams, and A. J. McMichael. 2011. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 76:540-548.
82. van der Mei, I. A., A. L. Ponsonby, L. Blizzard, and T. Dwyer. 2001. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 20:168-174.
83. van der Mei, I. A., A. L. Ponsonby, T. Dwyer, L. Blizzard, R. Simmons, B. V. Taylor, H. Butzkueven, and T. Kilpatrick. 2003. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study. British Medical Journal 327:316.
84. Dwyer, T., I. van der Mei, A. L. Ponsonby, B. V. Taylor, J. Stankovich, J. D. McKay, R. J. Thomson, A. M. Polanowski, and J. L. Dickinson. 2008. Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis. Neurology 71:583-589.
85. McDowell, T. Y., S. Amr, W. J. Culpepper, P. Langenberg, W. Royal, C. Bever, and D. D. Bradham. 2011. Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis. Neuroepidemiology 36:39-45.
86. Islam, T., W. J. Gauderman, W. Cozen, and T. M. Mack. 2007. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 69:381-388.
87. Kampman, M. T., T. Wilsgaard, and S. I. Mellgren. 2007. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. Journal of Neurology 254:471-477.
88. Dickinson, J., D. Perera, A. van der Mei, A. L. Ponsonby, A. Polanowski, R. Thomson, B. Taylor, J. McKay, J. Stankovich, and T. Dwyer. 2009. Past environmental sun exposure and risk of multiple sclerosis: A role for the Cdx-2 Vitamin D receptor variant in this interaction. Multiple Sclerosis (Houndmills, Basingstoke, England) 15:563-570.
89. Orton, S. M., L. Wald, C. Confavreux, S. Vukusic, J. P. Krohn, S. V. Ramagopalan, B. M. Herrera, A. D. Sadovnick, and G. C. Ebers. 2011. Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology 76:425-431.
90. Hine, T. J., and N. B. Roberts. 1994. Seasonal variation in serum 25-hydroxy vitamin D3 does not affect 1,25-dihydroxy vitamin D. Annals of Clinical Biochemistry 31 (Pt 1):31-34.
91. Archard, H. O. 1971. The dental defects of vitamin D-resistant rickets. Birth Defects Original Article Series 7:196-199.
92. Purvis, R. J., W. J. Barrie, G. S. MacKay, E. M. Wilkinson, F. Cockburn, and N. R. Belton. 1973. Enamel hypoplasia of the teeth associated with neonatal tetany: A manifestation of maternal vitamin-D deficiency. Lancet 2:811-814.
93. Berdal, A., N. Balmain, P. Cuisinier-Gleizes, and H. Mathieu. 1987. Histology and microradiography of early post-natal molar tooth development in vitamin-D deficient rats. Archives of Oral Biology 32:493-498.
94. Nishino, M., K. Kamada, K. Arita, and T. Takarada. 1990. [Dentofacial manifestations in children with vitamin D-dependent Rickets type II]. Shoni Shikagaku Zasshi 28:346-358.
95. Cosman, F., J. Nieves, J. Herbert, V. Shen, and R. Lindsay. 1994. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. Journal of Bone and Mineral Research 9:1097-1105.
96. Nieves, J., F. Cosman, J. Herbert, V. Shen, and R. Lindsay. 1994. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687-1692.
97. Cosman, F., J. Nieves, L. Komar, G. Ferrer, J. Herbert, C. Formica, V. Shen, and R. Lindsay. 1998. Fracture history and bone loss in patients with MS. Neurology 51:1161-1165.
98. Ascherio, A., and K. Munger. 2008. Epidemiology of multiple sclerosis: From risk factors to prevention. Seminars in Neurology 28:17-28.
99. Smolders, J., P. Menheere, A. Kessels, J. Damoiseaux, and R. Hupperts. 2008. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 14:1220-1224.
100. Correale, J., M. C. Ysrraelit, and M. I. Gaitan. 2009. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132:1146-1160.
101. Holmoy, T., S. M. Moen, T. A. Gundersen, M. F. Holick, E. Fainardi, M. Castellazzi, and I. Casetta. 2009. 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 15:1280-1285.
102. van der Mei, I. A., A. L. Ponsonby, T. Dwyer, L. Blizzard, B. V. Taylor, T. Kilpatrick, H. Butzkueven, and A. J. McMichael. 2007. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. Journal of Neurology 254:581-590.
103. Terzi, T., M. Terzi, B. Tander, F. Canturk, and M. Onar. 2010. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables. Journal of Clinical Neuroscience 17:1260-1264.
104. Neau, J. P., M. S. Artaud-Uriot, V. Lhomme, J. Y. Bounaud, F. Lebras, L. Boissonnot, N. Moinot, J. Ciron, D. Larrieu, S. Mathis, G. Godeneche, and P. Ingrand. 2011. [Vitamin D and multiple sclerosis. A prospective survey of patients of Poitou-Charentes area]. Revue Neurologique 167:317-323.
105. Munger, K. L., S. M. Zhang, E. O’Reilly, M. A. Hernan, M. J. Olek, W. C. Willett, and A. Ascherio. 2004. Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60-65.
106. Munger, K. L., L. I. Levin, B. W. Hollis, N. S. Howard, and A. Ascherio. 2006. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Journal of the American Medical Association 296:2832-2838.
107. Mirzaei, F., K. B. Michels, K. Munger, E. O’Reilly, T. Chitnis, M. R. Forman, E. Giovannucci, B. Rosner, and A. Ascherio. 2011. Gestational vitamin D and the risk of multiple sclerosis in offspring. Annals of Neurology 70:30-40.
108. Soilu-Hanninen, M., L. Airas, I. Mononen, A. Heikkila, M. Viljanen, and A. Hanninen. 2005. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 11:266-271.
109. Soilu-Hanninen, M., M. Laaksonen, I. Laitinen, J. P. Eralinna, E. M. Lilius, and I. Mononen. 2008. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 79:152-157.
110. Mowry, E. M., L. B. Krupp, M. Milazzo, D. Chabas, J. B. Strober, A. L. Belman, J. C. McDonald, J. R. Oksenberg, P. Bacchetti, and E. Waubant. 2010. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Annals of Neurology 67:618-624.
111. Simpson, S., B. Taylor, L. Blizzard, A.-L. Ponsonby, F. Pittas, H. Tremlett, T. Dwyer, P. Gies, and I. A. van der Mei. 2010. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Annals of Neurology 68:193-203.
112. Mealy, M. A., S. Newsome, B. M. Greenberg, D. Wingerchuk, P. Calabresi, and M. Levy. 2012. Low serum vitamin D levels and recurrent inflammatory spinal cord disease. Archives of Neurology 69:352-356.
113. Webb, A. R., L. Kline, and M. F. Holick. 1988. Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. The Journal of Clinical Endocrinology and Metabolism 67:373-378.
114. Hill, A. B. 1965. The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine 58:295-300.
115. Mowry, E. M. 2011. Vitamin D: Evidence for its role as a prognostic factor in multiple sclerosis. Journal of the Neurological Sciences 311:19-22.
116. Gourraud, P. A., J. P. McElroy, S. J. Caillier, B. A. Johnson, A. Santaniello, S. L. Hauser, and J. R. Oksenberg. 2011. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Annals of Neurology 69:65-74.
117. Berlanga-Taylor, A. J., G. Disanto, G. C. Ebers, and S. V. Ramagopalan. 2011. Vitamin D-gene interactions in multiple sclerosis. Journal of the Neurological Sciences 311:32-36.
118. Jersild, C., T. Fog, G. S. Hansen, M. Thomsen, A. Svejgaard, and B. Dupont. 1973. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet 2:1221-1225.
119. Okuda, D. T., R. Srinivasan, J. R. Oksenberg, D. S. Goodin, S. E. Baranzini, A. Beheshtian, E. Waubant, S. S. Zamvil, D. Leppert, P. Qualley, R. Lincoln, R. Gomez, S. Caillier, M. George, J. Wang, S. J. Nelson, B. A. Cree, S. L. Hauser, and D. Pelletier. 2009. Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 132:250-259.
120. Ramagopalan, S. V., N. J. Maugeri, L. Handunnetthi, M. R. Lincoln, S. M. Orton, D. A. Dyment, G. C. Deluca, B. M. Herrera, M. J. Chao, A. D. Sadovnick, G. C. Ebers, and J. C. Knight. 2009. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genetics 5:e1000369.
121. Smolders, J., E. Peelen, M. Thewissen, P. Menheere, J. W. Cohen Tervaert, R. Hupperts, and J. Damoiseaux. 2009. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmunity Reviews 8:621-626.
122. Huang, J., and Z. F. Xie. 2012. Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: A meta-analysis of case-control studies. Journal of the Neurological Sciences 313:79-85.
123. Orton, S. M., S. V. Ramagopalan, A. E. Para, M. R. Lincoln, L. Handunnetthi, M. J. Chao, J. Morahan, K. M. Morrison, A. D. Sadovnick, and G. C. Ebers. 2011. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. Journal of the Neurological Sciences 305:116-120.
124. Gross, C., A. V. Krishnan, P. J. Malloy, T. R. Eccleshall, X. Y. Zhao, and D. Feldman. 1998. The vitamin D receptor gene start codon polymorphism: A functional analysis of FokI variants. Journal of Bone and Mineral Research 13:1691-1699.
125. Jurutka, P. W., L. S. Remus, G. K. Whitfield, P. D. Thompson, J. C. Hsieh, H. Zitzer, P. Tavakkoli, M. A. Galligan, H. T. Dang, C. A. Haussler, and M. R. Haussler. 2000. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Molecular Endocrinology 14:401-420.
126. Smolders, J., J. Damoiseaux, P. Menheere, J. W. Tervaert, and R. Hupperts. 2009. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. Journal of Neuroimmunology 207:117-121.
127. Partridge, J. M., S. J. Weatherby, J. A. Woolmore, D. J. Highland, A. A. Fryer, C. L. Mann, M. D. Boggild, W. E. Ollier, R. C. Strange, and C. P. Hawkins. 2004. Susceptibility and outcome in MS: Associations with polymorphisms in pigmentation-related genes. Neurology 62:2323-2325.
128. Mamutse, G., J. Woolmore, E. Pye, J. Partridge, M. Boggild, C. Young, A. Fryer, P. R. Hoban, N. Rukin, J. Alldersea, R. C. Strange, and C. P. Hawkins. 2008. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 14:1280-1283.
129. Simon, K. C., K. L. Munger, Y. Xing, and A. Ascherio. 2010. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 16:133-138.
130. Arai, H., K. I. Miyamoto, M. Yoshida, H. Yamamoto, Y. Taketani, K. Morita, M. Kubota, S. Yoshida, M. Ikeda, F. Watabe, Y. Kanemasa, and E. Takeda. 2001. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. Journal of Bone and Mineral Research 16:1256-1264.
131. Sakaki, T., N. Kagawa, K. Yamamoto, and K. Inouye. 2005. Metabolism of vitamin D3 by cytochromes P450. Frontiers in Bioscience 10:119-134.
132. Yamamoto, K., E. Uchida, N. Urushino, T. Sakaki, N. Kagawa, N. Sawada, M. Kamakura, S. Kato, K. Inouye, and S. Yamada. 2005. Identification of the amino acid residue of CYP27B1 responsible for binding of 25-hydroxyvitamin D3 whose mutation causes vitamin D-dependent rickets type 1. Journal of Biological Chemistry 280:30511-30516.
133. Torkildsen, O., P. M. Knappskog, H. I. Nyland, and K. M. Myhr. 2008. Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Archives of Neurology 65:809-811.
134. Ramagopalan, S. V., H. E. Hanwell, G. Giovannoni, P. M. Knappskog, H. I. Nyland, K. M. Myhr, G. C. Ebers, and O. Torkildsen. 2010. Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis. Archives of Neurology 67:1034-1035.
135. Steckley, J. L., D. A. Dyment, A. D. Sadovnick, N. Risch, C. Hayes, and G. C. Ebers. 2000. Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology 54:729-732.
136. Ramagopalan, S. V., D. A. Dyment, M. Z. Cader, K. M. Morrison, G. Disanto, J. M. Morahan, A. J. Berlanga-Taylor, A. Handel, G. C. De Luca, A. D. Sadovnick, P. Lepage, A. Montpetit, and G. C. Ebers. 2011. Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Annals of Neurology 70:881-886.
137. Speeckaert, M., G. Huang, J. R. Delanghe, and Y. E. Taes. 2006. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clinica Chimica Acta 372:33-42.
138. Di Bacco, M., D. Luiselli, M. L. Manca, and G. Siciliano. 2002. Bayesian approach to searching for susceptibility genes: Gc2 and EsD1 alleles and multiple sclerosis. Collegium Antropologicum 26:77-84.
139. Hollsberg, P., S. Haahr, P. M. Larsen, and S. J. Fey. 1988. MS and the group-specific component. Acta Neurologica Scandinavica 78:158-160.
140. Lindblom, B., G. Wetterling, and H. Link. 1988. Distribution of group-specific component subtypes in multiple sclerosis. Acta Neurologica Scandinavica 78:443-444.
141. Niino, M., S. Kikuchi, T. Fukazawa, I. Yabe, and K. Tashiro. 2002. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. Journal of Neuroimmunology 127:177-179.
142. Burton, J. M., S. Kimball, R. Vieth, A. Bar-Or, H. M. Dosch, R. Cheung, D. Gagne, C. D’Souza, M. Ursell, and P. O’Connor. 2010. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74:1852-1859.
143. Kimball, S. M., M. R. Ursell, P. O’Connor, and R. Vieth. 2007. Safety of vitamin D3 in adults with multiple sclerosis. The American Journal of Clinical Nutrition 86:645-651.
144. Marcus, J. F., S. M. Shalev, C. A. Harris, D. S. Goodin, and S. A. Josephson. 2012. Severe hypercalcemia following vitamin D supplementation in a patient with multiple sclerosis: A note of caution. Archives of Neurology 69:129-132.
145. Soilu-Hanninen, M., J. Aivo, B. M. Lindstrom, I. Elovaara, M. L. Sumelahti, M. Farkkila, P. Tienari, S. Atula, T. Sarasoja, L. Herrala, I. Keskinarkaus, J. Kruger, T. Kallio, M. A. Rocca, and M. Filippi. 2012. A randomized, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 83:565-571.
146. Taylor, A. V., and P. H. Wise. 1998. Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgraduate Medical Journal 74:365-366.
147. Achiron, A., Y. Barak, S. Miron, Y. Izhak, M. Faibel, and S. Edelstein. 2003. Alfacalcidol treatment in multiple sclerosis. Clinical Neuropharmacology 26:53.
148. Wingerchuk, D. M., J. Lesaux, G. P. Rice, M. Kremenchutzky, and G. C. Ebers. 2005. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 76:1294-1296.
149. Hauser, S. L., H. L. Weiner, M. Che, M. E. Shapiro, F. Gilles, and N. L. Letvin. 1984. Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation. Journal of Immunology 132:1276-1281.
150. Becklund, B. R., K. S. Severson, S. V. Vang, and H. F. DeLuca. 2010. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proceedings of the National Academy of Sciences of the United States of America 107:6418-6423.
151. Tsunoda, I., L. Q. Kuang, I. Z. Igenge, and R. S. Fujinami. 2005. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation. Journal of Neuroimmunology 160:122-134.
152. Nashold, F. E., K. M. Spach, J. A. Spanier, and C. E. Hayes. 2009. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. Journal of Immunology 183:3672-3681.
153. Nataf, S., E. Garcion, F. Darcy, D. Chabannes, J. Y. Muller, and P. Brachet. 1996. 1,25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. Journal of Neuropathology and Experimental Neurology 55:904-914.
154. Garcion, E., S. Nataf, A. Berod, F. Darcy, and P. Brachet. 1997. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Research. Molecular Brain Research 45:255-267.
155. Nashold, F. E., D. J. Miller, and C. E. Hayes. 2000. 1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 103:171-179.
156. Garcion, E., L. Sindji, S. Nataf, P. Brachet, F. Darcy, and C. N. Montero-Menei. 2003. Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathologica 105:438-448.
157. Cantorna, M. T., W. D. Woodward, C. E. Hayes, and H. F. DeLuca. 1998. 1,25-Dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. Journal of Immunology 160:5314-5319.
158. Mattner, F., S. Smiroldo, F. Galbiati, M. Muller, P. Di Lucia, P. L. Poliani, G. Martino, P. Panina-Bordignon, and L. Adorini. 2000. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). European Journal of Immunology 30:498-508.
159. Goodin, D. S. 2009. The causal cascade to multiple sclerosis: A model for MS pathogenesis. PloS One 4:e4565.
160. Cantorna, M. T., J. Humpal-Winter, and H. F. DeLuca. 1999. Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. Journal of Nutrition 129:1966-1971.
161. Spach, K. M., F. E. Nashold, B. N. Dittel, and C. E. Hayes. 2006. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. Journal of Immunology 177:6030-6037.
162. Becklund, B. R., D. W. Hansen, Jr., and H. F. Deluca. 2009. Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin. Proceedings of the National Academy of Sciences of the United States of America 106:5276-5281.
163. Meehan, T. F., J. Vanhooke, J. Prahl, and H. F. Deluca. 2005. Hypercalcemia produced by parathyroid hormone suppresses experimental autoimmune encephalomyelitis in female but not male mice. Archives of Biochemistry and Biophysics 442:214-221.
164. Becklund, B. R., B. J. James, R. F. Gagel, and H. F. DeLuca. 2009. The calcitonin/calcitonin gene related peptide-alpha gene is not required for 1alpha,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis. Archives of Biochemistry and Biophysics 488:105-108.
165. Hewison, M. 2010. Vitamin D and the intracrinology of innate immunity. Molecular and Cellular Endocrinology 321:103-111.
166. Heine, G., U. Niesner, H. D. Chang, A. Steinmeyer, U. Zugel, T. Zuberbier, A. Radbruch, and M. Worm. 2008. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. European Journal of Immunology 38:2210-2218.
167. Sigmundsdottir, H., J. Pan, G. F. Debes, C. Alt, A. Habtezion, D. Soler, and E. C. Butcher. 2007. DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nature Immunology 8:285-293.
168. Enioutina, E. Y., D. Bareyan, and R. A. Daynes. 2009. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. Journal of Immunology 182:4296-4305.
169. Neveu, I., P. Naveilhan, C. Menaa, D. Wion, P. Brachet, and M. Garabedian. 1994. Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. Journal of Neuroscience Research 38:214-220.
170. Zehnder, D., R. Bland, M. C. Williams, R. W. McNinch, A. J. Howie, P. M. Stewart, and M. Hewison. 2001. Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. The Journal of Clinical Endocrinology and Metabolism 86:888-894.
171. Eyles, D. W., S. Smith, R. Kinobe, M. Hewison, and J. J. McGrath. 2005. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. Journal of Chemical Neuroanatomy 29:21-30.
172. Adorini, L., and G. Penna. 2009. Dendritic cell tolerogenicity: A key mechanism in immunomodulation by vitamin D receptor agonists. Human Immunology 70:345-352.
173. Fallarino, F., U. Grohmann, S. You, B. C. McGrath, D. R. Cavener, C. Vacca, C. Orabona, R. Bianchi, M. L. Belladonna, C. Volpi, P. Santamaria, M. C. Fioretti, and P. Puccetti. 2006. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. Journal of Immunology 176:6752-6761.
174. Curti, A., S. Pandolfi, B. Valzasina, M. Aluigi, A. Isidori, E. Ferri, V. Salvestrini, G. Bonanno, S. Rutella, I. Durelli, A. L. Horenstein, F. Fiore, M. Massaia, M. P. Colombo, M. Baccarani, and R. M. Lemoli. 2007. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood 109:2871-2877.
175. Gregori, S., N. Giarratana, S. Smiroldo, M. Uskokovic, and L. Adorini. 2002. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367-1374.
176. Daniel, C., N. A. Sartory, N. Zahn, H. H. Radeke, and J. M. Stein. 2008. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Journal of Pharmacology and Experimental Therapeutics 324:23-33.
177. Tang, J., R. Zhou, D. Luger, W. Zhu, P. B. Silver, R. S. Grajewski, S. B. Su, C. C. Chan, L. Adorini, and R. R. Caspi. 2009. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. Journal of Immunology 182:4624-4632.
178. Sakuishi, K., S. Miyake, and T. Yamamura. 2010. Role of NK cells and invariant NKT cells in multiple sclerosis. Results and Problems in Cell Differentiation 51:127-147.
179. Yu, S., and M. T. Cantorna. 2008. The vitamin D receptor is required for iNKT cell development. Proceedings of the National Academy of Sciences of the United States of America 105:5207-5212.
180. Yu, S., and M. T. Cantorna. 2011. Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. Journal of Immunology 186:1384-1390.
181. Wing, K., and S. Sakaguchi. 2010. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nature Immunology 11:7-13.
182. Sakaguchi, S., M. Miyara, C. M. Costantino, and D. A. Hafler. 2010. FOXP3+ regulatory T cells in the human immune system. Nature Reviews. Immunology 10:490-500.
183. Bailey-Bucktrout, S. L., and J. A. Bluestone. 2011. Regulatory T cells: Stability revisited. Trends in Immunology 32:301-306.
184. Venken, K., N. Hellings, R. Liblau, and P. Stinissen. 2010. Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends in Molecular Medicine 16:58-68.
185. Libera, D. D., D. D. Mitri, A. Bergami, D. Centonze, C. Gasperini, M. G. Grasso, S. Galgani, V. Martinelli, G. Comi, C. Avolio, G. Martino, G. Borsellino, F. Sallusto, L. Battistini, and R. Furlan. 2011. T regulatory cells are markers of disease activity in multiple sclerosis patients. PloS One 6:e21386.
186. Edwards, L. J., B. Sharrack, A. Ismail, H. Tumani, and C. S. Constantinescu. 2011. Central inflammation versus peripheral regulation in multiple sclerosis. Journal of Neurology 258:1518-1527.
187. Royal, W., 3rd, Y. Mia, H. Li, and K. Naunton. 2009. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. Journal of Neuroimmunology 213:135-141.
188. Smolders, J., M. Thewissen, E. Peelen, P. Menheere, J. W. Cohen Tervaert, J. Damoiseaux, and R. Hupperts. 2009. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 4:e6635.
189. Smolders, J., P. Menheere, M. Thewissen, E. Peelen, J. W. Cohen Tervaert, R. Hupperts, and J. Damoiseaux. 2010. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. The Journal of Steroid Biochemistry and Molecular Biology 121:243-246.
190. McGeachy, M. J., L. A. Stephens, and S. M. Anderton. 2005. Natural recovery and protection from autoimmune encephalomyelitis: Contribution of CD4+CD25+ regulatory cells within the central nervous system. Journal of Immunology 175:3025-3032.
191. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. Journal of Immunology 161:3299-3306.
192. Stohlman, S. A., L. Pei, D. J. Cua, Z. Li, and D. R. Hinton. 1999. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10. Journal of Immunology 163:6338-6344.
193. Burkhart, C., G. Y. Liu, S. M. Anderton, B. Metzler, and D. C. Wraith. 1999. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: A role for IL-10. International Immunology 11:1625-1634.
194. Sundstedt, A., E. J. O’Neill, K. S. Nicolson, and D. C. Wraith. 2003. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. Journal of Immunology 170:1240-1248.
195. Zhang, X., D. N. Koldzic, L. Izikson, J. Reddy, R. F. Nazareno, S. Sakaguchi, V. K. Kuchroo, and H. L. Weiner. 2004. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. International Immunology 16:249-256.
196. Lemire, J. M., and D. C. Archer. 1991. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. Journal of Clinical Investigation 87:1103-1107.
197. Chang, J. H., H. R. Cha, D. S. Lee, K. Y. Seo, and M. N. Kweon. 2010. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 5:e12925.
198. Joshi, S., L. C. Pantalena, X. K. Liu, S. L. Gaffen, H. Liu, C. Rohowsky-Kochan, K. Ichiyama, A. Yoshimura, L. Steinman, S. Christakos, and S. Youssef. 2011. 1,25-Dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Molecular and Cellular Biology 31:3653-3669.
199. Loser, K., and S. Beissert. 2009. Regulation of cutaneous immunity by the environment: An important role for UV irradiation and vitamin D. International Immunopharmacology 9:587-589.
200. Ghoreishi, M., P. Bach, J. Obst, M. Komba, J. C. Fleet, and J. P. Dutz. 2009. Expansion of antigen-specific regulatory T cells with the topical vitamin D analog calcipotriol. Journal of Immunology 182:6071-6078.
201. Muller, K., J. Gram, J. Bollerslev, M. Diamant, T. Barington, M. B. Hansen, and K. Bendtzen. 1991. Down-regulation of monocyte functions by treatment of healthy adults with 1 alpha,25 dihydroxyvitamin D3. International Journal of Immunopharmacology 13:525-530.
202. Mahon, B. D., S. A. Gordon, J. Cruz, F. Cosman, and M. T. Cantorna. 2003. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. Journal of Neuroimmunology 134:128-132.
203. Cantorna, M. T., J. Humpal-Winter, and H. F. DeLuca. 2000. In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). Archives of Biochemistry and Biophysics 377:135-138.
204. Spach, K. M., L. B. Pedersen, F. E. Nashold, T. Kayo, B. S. Yandell, T. A. Prolla, and C. E. Hayes. 2004. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiological Genomics 18:141-151.
205. Pedersen, L. B., F. E. Nashold, K. M. Spach, and C. E. Hayes. 2007. 1,25-Dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. Journal of Neuroscience Research 85:2480-2490.
206. Santamaria, P. 2010. The long and winding road to understanding and conquering type 1 diabetes. Immunity 32:437-445.
207. Lehuen, A., J. Diana, P. Zaccone, and A. Cooke. 2010. Immune cell crosstalk in type 1 diabetes. Nature Reviews. Immunology 10:501-513.
208. Todd, J. A. 2010. Etiology of type 1 diabetes. Immunity 32:457-467.
209. Bluestone, J. A., K. Herold, and G. Eisenbarth. 2010. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293-1300.
210. Maahs, D. M., N. A. West, J. M. Lawrence, and E. J. Mayer-Davis. 2010. Epidemiology of type 1 diabetes. Endocrinology and Metabolism Clinics of North America 39:481-497.
211. Steck, A. K., and M. J. Rewers. 2011. Genetics of type 1 diabetes. Clinical Chemistry 57:176-185.
212. Baz-Hecht, M., and A. B. Goldfine. 2010. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Current Opinion in Endocrinology, Diabetes, and Obesity 17:113-119.
213. Hypponen, E. 2010. Vitamin D and increasing incidence of type 1 diabetes-evidence for an association? Diabetes, Obesity & Metabolism 12:737-743.
214. Balay, J. L. 2010. Vitamin D. What is its role in diabetes? Diabetes Self-Management 27:11-14.
215. Mathieu, C. 2010. Vitamin D and diabetes: The devil is in the D-tails. Diabetologia 53:1545-1548.
216. Mitri, J., and A. G. Pittas. 2010. Diabetes-Shining a light: The role of vitamin D in diabetes mellitus. Nature Reviews. Endocrinology 6:478-480.
217. Mohr, S. B., F. C. Garland, C. F. Garland, E. D. Gorham, and C. Ricordi. 2010. Is there a role of vitamin D deficiency in type 1 diabetes of children? American Journal of Preventive Medicine 39:189-190.
218. Pittas, A. G., and B. Dawson-Hughes. 2010. Vitamin D and diabetes. The Journal of Steroid Biochemistry and Molecular Biology 121:425-429.
219. Takiishi, T., C. Gysemans, R. Bouillon, and C. Mathieu. 2010. Vitamin D and diabetes. Endocrinology and Metabolism Clinics of North America 39:419-446.
220. Boucher, B. J. 2011. Vitamin D insufficiency and diabetes risks. Current Drug Targets 12:61-87.
221. Hayes, C. E., F. E. Nashold, K. M. Spach, and L. B. Pedersen. 2003. The immunological functions of the vitamin D endocrine system. Cellular and Molecular Biology (Noisy-le-Grand, France) 49:277-300.
222. Mohr, S. B., C. F. Garland, E. D. Gorham, and F. C. Garland. 2008. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51:1391-1398.
223. Pugliatti, M., S. Sotgiu, G. Solinas, P. Castiglia, M. I. Pirastru, B. Murgia, L. Mannu, G. Sanna, and G. Rosati. 2001. Multiple sclerosis epidemiology in Sardinia: Evidence for a true increasing risk. Acta Neurologica Scandinavica 103:20-26.
224. Kahn, H. S., T. M. Morgan, L. D. Case, D. Dabelea, E. J. Mayer-Davis, J. M. Lawrence, S. M. Marcovina, and G. Imperatore. 2009. Association of type 1 diabetes with month of birth among U.S. youth: The SEARCH for Diabetes in Youth Study. Diabetes Care 32:2010-2015.
225. Levy-Marchal, C., C. Patterson, and A. Green. 1995. Variation by age group and seasonality at diagnosis of childhood IDDM in Europe. The EURODIAB ACE Study Group. Diabetologia 38:823-830.
226. Karvonen, M., V. Jantti, S. Muntoni, M. Stabilini, L. Stabilini, and J. Tuomilehto. 1998. Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia. Diabetes Care 21:1101-1109.
227. Pozzilli, P., S. Manfrini, A. Crino, A. Picardi, C. Leomanni, V. Cherubini, L. Valente, M. Khazrai, and N. Visalli. 2005. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Hormone and Metabolic Research 37:680-683.
228. Sloka, S., M. Grant, and L. A. Newhook. 2008. Time series analysis of ultraviolet B radiation and type 1 diabetes in Newfoundland. Pediatric Diabetes 9:81-86.
229. Gorham, E. D., E. Barrett-Connor, R. M. Highfill-McRoy, S. B. Mohr, C. F. Garland, F. C. Garland, and C. Ricordi. 2009. Incidence of insulin-requiring diabetes in the US military. Diabetologia 52:2087-2091.
230. Elliott, J. C., R. M. Lucas, M. S. Clements, and H. J. Bambrick. 2010. Population density determines the direction of the association between ambient ultraviolet radiation and type 1 diabetes incidence. Pediatric Diabetes 11:394-402.
231. Cooper, J. D., D. J. Smyth, N. M. Walker, H. Stevens, O. S. Burren, C. Wallace, C. Greissl, E. Ramos-Lopez, E. Hypponen, D. B. Dunger, T. D. Spector, W. H. Ouwehand, T. J. Wang, K. Badenhoop, and J. A. Todd. 2011. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 60:1624-1631.
232. Moltchanova, E. V., N. Schreier, N. Lammi, and M. Karvonen. 2009. Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide. Diabetic Medicine 26:673-678.
233. Godar, D. E. 2005. UV doses worldwide. Photochemistry and Photobiology 81:736-749.
234. Staples, J. A., A. L. Ponsonby, L. L. Lim, and A. J. McMichael. 2003. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: Latitude, regional ultraviolet radiation, and disease prevalence. Environmental Health Perspectives 111:518-523.
235. Ponsonby, A. L., R. M. Lucas, and I. A. van der Mei. 2005. UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochemistry and Photobiology 81:1267-1275.
236. Sloka, S., M. Grant, and L. A. Newhook. 2010. The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland. Acta Diabetologica 47:73-78.
237. Christakos, S., and A. W. Norman. 1979. Studies on the mode of action of calciferol. XVIII. Evidence for a specific high affinity binding protein for 1,25 dihydroxyvitamin D3 in chick kidney and pancreas. Biochemical and Biophysical Research Communications 89:56-63.
238. Clark, S. A., W. E. Stumpf, M. Sar, H. F. DeLuca, and Y. Tanaka. 1980. Target cells for 1,25 dihydroxyvitamin D3 in the pancreas. Cell and Tissue Research 209:515-520.
239. Pike, J. W. 1982. Receptors for 1,25-dihydroxyvitamin D3 in chick pancreas: A partial physical and functional characterization. Journal of Steroid Biochemistry 16:385-395.
240. Bland, R., D. Markovic, C. E. Hills, S. V. Hughes, S. L. Chan, P. E. Squires, and M. Hewison. 2004. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. The Journal of Steroid Biochemistry and Molecular Biology 89-90:121-125.
241. Norman, A. W., J. B. Frankel, A. M. Heldt, and G. M. Grodsky. 1980. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209:823-825.
242. Chertow, B. S., W. I. Sivitz, N. G. Baranetsky, S. A. Clark, A. Waite, and H. F. Deluca. 1983. Cellular mechanisms of insulin release: The effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113:1511-1518.
243. Tanaka, Y., Y. Seino, M. Ishida, K. Yamaoka, H. Yabuuchi, H. Ishida, S. Seino, and H. Imura. 1984. Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta Endocrinologica 105:528-533.
244. Kadowaki, S., and A. W. Norman. 1984. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. The Journal of Clinical Investigation 73:759-766.
245. Cade, C., and A. W. Norman. 1986. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 119:84-90.
246. Kumar, S., M. Davies, Y. Zakaria, E. B. Mawer, C. Gordon, A. O. Olukoga, and A. J. Boulton. 1994. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgraduate Medical Journal 70:440-443.
247. Clark, S. A., W. E. Stumpf, and M. Sar. 1981. Effect of 1,25 dihydroxyvitamin D3 on insulin secretion. Diabetes 30:382-386.
248. Cade, C., and A. W. Norman. 1987. Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 120:1490-1497.
249. Hay, C. W., and K. Docherty. 2006. Comparative analysis of insulin gene promoters: Implications for diabetes research. Diabetes 55:3201-3213.
250. Mathieu, C., and K. Badenhoop. 2005. Vitamin D and type 1 diabetes mellitus: State of the art. Trends in Endocrinology and Metabolism 16:261-266.
251. 1999. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 42:51-54.
252. Zipitis, C. S., and A. K. Akobeng. 2008. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Archives of Disease in Childhood 93:512-517.
253. Hypponen, E., E. Laara, A. Reunanen, M. R. Jarvelin, and S. M. Virtanen. 2001. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 358:1500-1503.
254. Holick, M. F. 1995. Environmental factors that influence the cutaneous production of vitamin D. The American Journal of Clinical Nutrition 61:638S-645S.
255. Fronczak, C. M., A. E. Baron, H. P. Chase, C. Ross, H. L. Brady, M. Hoffman, G. S. Eisenbarth, M. Rewers, and J. M. Norris. 2003. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 26:3237-3242.
256. Need, A. G., P. D. O’Loughlin, M. Horowitz, and B. E. Nordin. 2005. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clinical Endocrinology 62:738-741.
257. Littorin, B., P. Blom, A. Scholin, H. J. Arnqvist, G. Blohme, J. Bolinder, A. Ekbom-Schnell, J. W. Eriksson, S. Gudbjornsdottir, L. Nystrom, J. Ostman, and G. Sundkvist. 2006. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: Results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 49:2847-2852.
258. Greer, R. M., M. A. Rogers, F. G. Bowling, H. M. Buntain, M. Harris, G. M. Leong, and A. M. Cotterill. 2007. Australian children and adolescents with type 1 diabetes have low vitamin D levels. The Medical Journal of Australia 187:59-60.
259. Svoren, B. M., L. K. Volkening, J. R. Wood, and L. M. Laffel. 2009. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. Journal of Pediatrics 154:132-134.
260. Devaraj, S., J. M. Yun, C. R. Duncan-Staley, and I. Jialal. 2011. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. American Journal of Clinical Pathology 135:429-433.
261. Janner, M., P. Ballinari, P. E. Mullis, and C. E. Fluck. 2010. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Medical Weekly 140:w13091.
262. Hamed, E. A., N. H. Abu Faddan, H. A. Adb Elhafeez, and D. Sayed. 2011. Parathormone-25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus. Pediatric Diabetes 12:536-546.
263. Young, K. A., J. K. Snell-Bergeon, R. G. Naik, J. E. Hokanson, D. Tarullo, P. A. Gottlieb, S. K. Garg, and M. Rewers. 2011. Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes. Diabetes Care 34:454-458.
264. Kaur, H., K. C. Donaghue, A. K. Chan, P. Benitez-Aguirre, S. Hing, M. Lloyd, J. Cusumano, A. Pryke, and M. E. Craig. 2011. Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes. Diabetes Care 34:1400-1402.
265. Hyttinen, V., J. Kaprio, L. Kinnunen, M. Koskenvuo, and J. Tuomilehto. 2003. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: A nationwide follow-up study. Diabetes 52:1052-1055.
266. Redondo, M. J., J. Jeffrey, P. R. Fain, G. S. Eisenbarth, and T. Orban. 2008. Concordance for islet autoimmunity among monozygotic twins. The New England Journal of Medicine 359:2849-2850.
267. McDermott, M. F., A. Ramachandran, B. W. Ogunkolade, E. Aganna, D. Curtis, B. J. Boucher, C. Snehalatha, and G. A. Hitman. 1997. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 40:971-975.
268. Pani, M. A., M. Knapp, H. Donner, J. Braun, M. P. Baur, K. H. Usadel, and K. Badenhoop. 2000. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 49:504-507.
269. Pociot, F., B. Akolkar, P. Concannon, H. A. Erlich, C. Julier, G. Morahan, C. R. Nierras, J. A. Todd, S. S. Rich, and J. Nerup. 2010. Genetics of type 1 diabetes: What’s next? Diabetes 59:1561-1571.
270. Turpeinen, H., R. Hermann, S. Vaara, A. P. Laine, O. Simell, M. Knip, R. Veijola, and J. Ilonen. 2003. Vitamin D receptor polymorphisms: No association with type 1 diabetes in the Finnish population. European Journal of Endocrinology/European Federation of Endocrine Societies 149:591-596.
271. Martin, R. J., A. J. McKnight, C. C. Patterson, D. M. Sadlier, and A. P. Maxwell. 2010. A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association-European Renal Association 25:497-503.
272. Chang, T. J., H. H. Lei, J. I. Yeh, K. C. Chiu, K. C. Lee, M. C. Chen, T. Y. Tai, and L. M. Chuang. 2000. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clinical Endocrinology 52:575-580.
273. Nguyen, M., A. d’Alesio, J. M. Pascussi, R. Kumar, M. D. Griffin, X. Dong, H. Guillozo, M. Rizk-Rabin, C. Sinding, P. Bougneres, F. Jehan, and M. Garabedian. 2006. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): Dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3. Journal of Bone and Mineral Research 21:886-894.
274. Guo, S. W., V. L. Magnuson, J. J. Schiller, X. Wang, Y. Wu, and S. Ghosh. 2006. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: A HuGE review of genetic association studies. American Journal of Epidemiology 164:711-724.
275. Mimbacas, A., J. Trujillo, C. Gascue, G. Javiel, and H. Cardoso. 2007. Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus. Genetics and Molecular Research 6:534-542.
276. Lemos, M. C., A. Fagulha, E. Coutinho, L. Gomes, M. Bastos, L. Barros, F. Carrilho, E. Geraldes, F. J. Regateiro, and M. Carvalheiro. 2008. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Human Immunology 69:134-138.
277. Kahles, H., G. Morahan, J. A. Todd, and K. Badenhoop. 2009. Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes. Genes and Immunity 10 Suppl 1:S60-63.
278. Mory, D. B., E. R. Rocco, W. L. Miranda, T. Kasamatsu, F. Crispim, and S. A. Dib. 2009. Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to beta-cell autoimmunity and to remaining beta-cell function. Human Immunology 70:447-451.
279. Mohammadnejad, Z., M. Ghanbari, R. Ganjali, J. T. Afshari, M. Heydarpour, S. M. Taghavi, S. Fatemi, and H. Rafatpanah. 2011. Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Molecular Biology Reports 39:831-837.
280. Ponsonby, A. L., A. Pezic, J. Ellis, R. Morley, F. Cameron, J. Carlin, and T. Dwyer. 2008. Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: A meta-regression analysis. American Journal of Epidemiology 168:358-365.
281. Gross, C., A. V. Krishnan, P. J. Malloy, T. R. Eccleshall, X. Y. Zhao, and D. Feldman. 1998. The vitamin D receptor gene start codon polymorphism: A functional analysis of FokI variants. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research 13:1691-1699.
282. van Etten, E., L. Verlinden, A. Giulietti, E. Ramos-Lopez, D. D. Branisteanu, G. B. Ferreira, L. Overbergh, A. Verstuyf, R. Bouillon, B. O. Roep, K. Badenhoop, and C. Mathieu. 2007. The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system. European Journal of Immunology 37:395-405.
283. Zella, L. A., M. B. Meyer, R. D. Nerenz, S. M. Lee, M. L. Martowicz, and J. W. Pike. 2010. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Molecular Endocrinology 24:128-147.
284. Israni, N., R. Goswami, A. Kumar, and R. Rani. 2009. Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India. PLoS One 4:e8023.
285. Cheng, J. B., M. A. Levine, N. H. Bell, D. J. Mangelsdorf, and D. W. Russell. 2004. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proceedings of the National Academy of Sciences of the United States of America 101:7711-7715.
286. Wang, T. J., F. Zhang, J. B. Richards, B. Kestenbaum, J. B. van Meurs, D. Berry, D. P. Kiel, E. A. Streeten, C. Ohlsson, D. L. Koller, L. Peltonen, J. D. Cooper, P. F. O’Reilly, D. K. Houston, N. L. Glazer, L. Vandenput, M. Peacock, J. Shi, F. Rivadeneira, M. I. McCarthy, P. Anneli, I. H. de Boer, M. Mangino, B. Kato, D. J. Smyth, S. L. Booth, P. F. Jacques, G. L. Burke, M. Goodarzi, C. L. Cheung, M. Wolf, K. Rice, D. Goltzman, N. Hidiroglou, M. Ladouceur, N. J. Wareham, L. J. Hocking, D. Hart, N. K. Arden, C. Cooper, S. Malik, W. D. Fraser, A. L. Hartikainen, G. Zhai, H. M. Macdonald, N. G. Forouhi, R. J. Loos, D. M. Reid, A. Hakim, E. Dennison, Y. Liu, C. Power, H. E. Stevens, L. Jaana, R. S. Vasan, N. Soranzo, J. Bojunga, B. M. Psaty, M. Lorentzon, T. Foroud, T. B. Harris, A. Hofman, J. O. Jansson, J. A. Cauley, A. G. Uitterlinden, Q. Gibson, M. R. Jarvelin, D. Karasik, D. S. Siscovick, M. J. Econs, S. B. Kritchevsky, J. C. Florez, J. A. Todd, J. Dupuis, E. Hypponen, and T. D. Spector. 2010. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 376:180-188.
287. Ramos-Lopez, E., P. Bruck, T. Jansen, J. Herwig, and K. Badenhoop. 2007. CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes Metab Res Rev 23:631-636.
288. Lopez, E. R., O. Zwermann, M. Segni, G. Meyer, M. Reincke, J. Seissler, J. Herwig, K. H. Usadel, and K. Badenhoop. 2004. A promoter polymorphism of the CYP27B1 gene is associated with Addison’s disease, Hashimoto’s thyroiditis, Graves’ disease and type 1 diabetes mellitus in Germans. European Journal of Endocrinology/European Federation of Endocrine Societies 151:193-197.
289. Lopez, E. R., K. Regulla, M. A. Pani, M. Krause, K. H. Usadel, and K. Badenhoop. 2004. CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans. The Journal of Steroid Biochemistry and Molecular Biology 89-90:155-157.
290. Bailey, R., J. D. Cooper, L. Zeitels, D. J. Smyth, J. H. Yang, N. M. Walker, E. Hypponen, D. B. Dunger, E. Ramos-Lopez, K. Badenhoop, S. Nejentsev, and J. A. Todd. 2007. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56:2616-2621.
291. Pani, M. A., K. Regulla, M. Segni, M. Krause, S. Hofmann, M. Hufner, J. Herwig, A. M. Pasquino, K. H. Usadel, and K. Badenhoop. 2002. Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves’ disease, Hashimoto’s thyroiditis and type 1 diabetes mellitus. European Journal of Endocrinology/European Federation of Endocrine Societies 146:777-781.
292. Fichna, M., M. Zurawek, D. Januszkiewicz-Lewandowska, P. Fichna, and J. Nowak. 2010. PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients. International Journal of Immunogenetics 37:367-372.
293. Ongagna, J. C., M. C. Kaltenbacher, R. Sapin, M. Pinget, and A. Belcourt. 2001. The HLA-DQB alleles and amino acid variants of the vitamin D-binding protein in diabetic patients in Alsace. Clinical Biochemistry 34:59-63.
294. Ongagna, J. C., M. Pinget, and A. Belcourt. 2005. Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes. Clinical Biochemistry 38:415-419.
295. Brekke, H. K., and J. Ludvigsson. 2007. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatric Diabetes 8:11-14.
296. Marjamaki, L., S. Niinisto, M. G. Kenward, L. Uusitalo, U. Uusitalo, M. L. Ovaskainen, C. Kronberg-Kippila, O. Simell, R. Veijola, J. Ilonen, M. Knip, and S. M. Virtanen. 2010. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 53:1599-1607.
297. Barger-Lux, M. J., R. P. Heaney, S. Dowell, T. C. Chen, and M. F. Holick. 1998. Vitamin D and its major metabolites: Serum levels after graded oral dosing in healthy men. Osteoporosis International 8:222-230.
298. Vieth, R. 2004. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. The Journal of Steroid Biochemistry and Molecular Biology 89-90:575-579.
299. Heaney, R. P., L. A. Armas, J. R. Shary, N. H. Bell, N. Binkley, and B. W. Hollis. 2008. 25-Hydroxylation of vitamin D3: Relation to circulating vitamin D3 under various input conditions. The American Journal of Clinical Nutrition 87:1738-1742.
300. Bischoff-Ferrari, H. A., A. Shao, B. Dawson-Hughes, J. Hathcock, E. Giovannucci, and W. C. Willett. 2010. Benefit-risk assessment of vitamin D supplementation. Osteoporosis International 21:1121-1132.
301. Gedik, O., and S. Akalin. 1986. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29:142-145.
302. Aljabri, K. S., S. A. Bokhari, and M. J. Khan. 2010. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Annals of Saudi Medicine 30:454-458.
303. Armas, L. A., B. W. Hollis, and R. P. Heaney. 2004. Vitamin D2 is much less effective than vitamin D3 in humans. The Journal of Clinical Endocrinology and Metabolism 89:5387-5391.
304. Houghton, L. A., and R. Vieth. 2006. The case against ergocalciferol (vitamin D2) as a vitamin supplement. The American Journal of Clinical Nutrition 84:694-697.
305. Walter, M., T. Kaupper, K. Adler, J. Foersch, E. Bonifacio, and A. G. Ziegler. 2010. No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 33:1443-1448.
306. Orwoll, E., M. Riddle, and M. Prince. 1994. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. The American Journal of Clinical Nutrition 59:1083-1087.
307. Bizzarri, C., D. Pitocco, N. Napoli, E. Di Stasio, D. Maggi, S. Manfrini, C. Suraci, M. G. Cavallo, M. Cappa, G. Ghirlanda, and P. Pozzilli. 2010. No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: The IMDIAB XIII trial. Diabetes Care 33:1962-1963.
308. Kishimoto, H., and J. Sprent. 2001. A defect in central tolerance in NOD mice. Nature Immunology 2:1025-1031.
309. Driver, J. P., D. V. Serreze, and Y. G. Chen. 2011. Mouse models for the study of autoimmune type 1 diabetes: A NOD to similarities and differences to human disease. Seminars in Immunopathology 33:67-87.
310. Mathieu, C., E. van Etten, B. Decallonne, A. Guilietti, C. Gysemans, R. Bouillon, and L. Overbergh. 2004. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. The Journal of Steroid Biochemistry and Molecular Biology 89-90:449-452.
311. Giulietti, A., C. Gysemans, K. Stoffels, E. van Etten, B. Decallonne, L. Overbergh, R. Bouillon, and C. Mathieu. 2004. Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 47:451-462.
312. Zella, J. B., L. C. McCary, and H. F. DeLuca. 2003. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Archives of Biochemistry and Biophysics 417:77-80.
313. Hawa, M. I., M. G. Valorani, L. R. Buckley, P. E. Beales, A. Afeltra, F. Cacciapaglia, R. D. Leslie, and P. Pozzilli. 2004. Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse. Hormone and Metabolic Research 36:620-624.
314. Overbergh, L., B. Decallonne, D. Valckx, A. Verstuyf, J. Depovere, J. Laureys, O. Rutgeerts, R. Saint-Arnaud, R. Bouillon, and C. Mathieu. 2000. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clinical and Experimental Immunology 120:139-146.
315. Mathieu, C., M. Waer, J. Laureys, O. Rutgeerts, and R. Bouillon. 1994. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 37:552-558.
316. Gysemans, C. A., A. K. Cardozo, H. Callewaert, A. Giulietti, L. Hulshagen, R. Bouillon, D. L. Eizirik, and C. Mathieu. 2005. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: Implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 146:1956-1964.
317. Wolden-Kirk, H., L. Overbergh, H. T. Christesen, K. Brusgaard, and C. Mathieu. 2011. Vitamin D and diabetes: Its importance for beta cell and immune function. Molecular and Cellular Endocrinology 347:106-120.
318. Ogunkolade, B. W., B. J. Boucher, J. M. Prahl, S. A. Bustin, J. M. Burrin, K. Noonan, B. V. North, N. Mannan, M. F. McDermott, H. F. DeLuca, and G. A. Hitman. 2002. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51:2294-2300.
319. Zeitz, U., K. Weber, D. W. Soegiarto, E. Wolf, R. Balling, and R. G. Erben. 2003. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB Journal 17:509-511.
320. Schneider, L. E., H. P. Schedl, T. McCain, and M. R. Haussler. 1977. Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat. Science 196:1452-1454.
321. Bikle, D. D. 2011. Vitamin D: An ancient hormone. Experimental Dermatology 20:7-13.
322. Sibley, R. K., D. E. Sutherland, F. Goetz, and A. F. Michael. 1985. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Laboratory Investigation 53:132-144.
323. Uno, S., A. Imagawa, K. Okita, K. Sayama, M. Moriwaki, H. Iwahashi, K. Yamagata, S. Tamura, Y. Matsuzawa, T. Hanafusa, J. Miyagawa, and I. Shimomura. 2007. Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes. Diabetologia 50:596-601.
324. Du, T., Z. G. Zhou, S. You, J. Lin, L. Yang, W. D. Zhou, G. Huang, and C. Chao. 2009. Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clinica Chimica Acta; International Journal of Clinical Chemistry 402:133-138.
325. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-650.
326. Gombart, A. F. 2009. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiology 4:1151-1165.
327. Beard, J. A., A. Bearden, and R. Striker. 2011. Vitamin D and the anti-viral state. Journal of Clinical Virology 50:194-200.
328. Baeke, F., T. Takiishi, H. Korf, C. Gysemans, and C. Mathieu. 2010. Vitamin D: Modulator of the immune system. Current Opinion in Pharmacology 10:482-496.
329. Bikle, D. D. 2011. Vitamin D regulation of immune function. Vitamins and Hormones 86:1-21.
330. Adorini, L. 2003. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Annals of the New York Academy of Sciences 987:258-261.
331. van Etten, E., O. Dardenne, C. Gysemans, L. Overbergh, and C. Mathieu. 2004. 1,25-Dihydroxyvitamin D3 alters the profile of bone marrow-derived dendritic cells of NOD mice. Annals of the New York Academy of Sciences 1037:186-192.
332. Adorini, L., and G. Penna. 2009. Dendritic cell tolerogenicity: A key mechanism in immunomodulation by vitamin D receptor agonists. Human Immunology 70:345-352.
333. Gysemans, C., E. van Etten, L. Overbergh, A. Giulietti, G. Eelen, M. Waer, A. Verstuyf, R. Bouillon, and C. Mathieu. 2008. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor. Diabetes 57:269-275.
334. Leung, K. H. 1989. Inhibition of human natural killer cell and lymphokine-activated killer cell cytotoxicity and differentiation by vitamin D3. Scandinavian Journal of Immunology 30:199-208.
335. Qin, H., I. F. Lee, C. Panagiotopoulos, X. Wang, A. D. Chu, P. J. Utz, J. J. Priatel, and R. Tan. 2011. Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling. Diabetes 60:857-866.
336. Deniz, G., G. Erten, U. C. Kucuksezer, D. Kocacik, C. Karagiannidis, E. Aktas, C. A. Akdis, and M. Akdis. 2008. Regulatory NK cells suppress antigen-specific T cell responses. Journal of Immunology 180:850-857.
337. Jeffery, L. E., F. Burke, M. Mura, Y. Zheng, O. S. Qureshi, M. Hewison, L. S. Walker, D. A. Lammas, K. Raza, and D. M. Sansom. 2009. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. Journal of Immunology 183:5458-5467.
338. Baeke, F., H. Korf, L. Overbergh, A. Verstuyf, L. Thorrez, L. Van Lommel, M. Waer, F. Schuit, C. Gysemans, and C. Mathieu. 2011. The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. Journal of Immunology 186:132-142.
339. Zhou, X., S. L. Bailey-Bucktrout, L. T. Jeker, C. Penaranda, M. Martinez-Llordella, M. Ashby, M. Nakayama, W. Rosenthal, and J. A. Bluestone. 2009. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nature Immunology 10:1000-1007.
340. O’Shea, J. J., and W. E. Paul. 2010. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327:1098-1102.
341. Brusko, T., C. Wasserfall, K. McGrail, R. Schatz, H. L. Viener, D. Schatz, M. Haller, J. Rockell, P. Gottlieb, M. Clare-Salzler, and M. Atkinson. 2007. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56:604-612.
342. McClymont, S. A., A. L. Putnam, M. R. Lee, J. H. Esensten, W. Liu, M. A. Hulme, U. Hoffmuller, U. Baron, S. Olek, J. A. Bluestone, and T. M. Brusko. 2011. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. Journal of Immunology 186:3918-3926.
343. von Essen, M. R., M. Kongsbak, P. Schjerling, K. Olgaard, N. Odum, and C. Geisler. 2010. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nature Immunology 11:344-349.
344. Baeke, F., H. Korf, L. Overbergh, E. van Etten, A. Verstuyf, C. Gysemans, and C. Mathieu. 2010. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. The Journal of Steroid Biochemistry and Molecular Biology 121:221-227.
345. Correale, J., M. C. Ysrraelit, and M. I. Gaitan. 2010. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. Journal of Immunology 185:4948-4958.
346. Lesage, S., S. B. Hartley, S. Akkaraju, J. Wilson, M. Townsend, and C. C. Goodnow. 2002. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. Journal of Experimental Medicine 196:1175-1188.
347. Colucci, F., M. L. Bergman, C. Penha-Goncalves, C. M. Cilio, and D. Holmberg. 1997. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proceedings of the National Academy of Sciences of the United States of America 94:8670-8674.
348. Decallonne, B., and C. Mathieu. 2003. Defective activation-induced cell death in NOD T lymphocytes: 1,25-dihydroxyvitamin D3 restores defect. Annals of the New York Academy of Sciences 1005:176-177.
349. Decallonne, B., E. van Etten, A. Giulietti, K. Casteels, L. Overbergh, R. Bouillon, and C. Mathieu. 2003. Defect in activation-induced cell death in non-obese diabetic (NOD) T lymphocytes. Journal of Autoimmunity 20:219-226.
350. Decallonne, B., E. van Etten, L. Overbergh, D. Valckx, R. Bouillon, and C. Mathieu. 2005. 1Alpha,25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cells. Journal of Autoimmunity 24:281-289.
351. Imai, Y., T. Kimura, A. Murakami, N. Yajima, K. Sakamaki, and S. Yonehara. 1999. The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 398:777-785.
352. Zheng, C., V. Kabaleeswaran, Y. Wang, G. Cheng, and H. Wu. 2010. Crystal structures of the TRAF2:cIAP2 and the TRAF1:TRAF2:cIAP2 complexes: Affinity, specificity, and regulation. Molecular Cell 38:101-113.
353. Khor, B., A. Gardet, and R. J. Xavier. 2011. Genetics and pathogenesis of inflammatory bowel disease. Nature 474:307-317.
354. Maloy, K. J., and F. Powrie. 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474:298-306.
355. Hardenberg, G., T. S. Steiner, and M. K. Levings. 2011. Environmental influences on T regulatory cells in inflammatory bowel disease. Seminars in Immunology 23:130-138.
356. Kaser, A., S. Zeissig, and R. S. Blumberg. 2010. Inflammatory bowel disease. Annual Review of Immunology 28:573-621.
357. Koboziev, I., F. Karlsson, and M. B. Grisham. 2010. Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation. Annals of the New York Academy of Sciences 1207 Suppl 1:E86-93.
358. Weaver, C. T., and R. D. Hatton. 2009. Interplay between the TH17 and TReg cell lineages: A (co-)evolutionary perspective. Nature Reviews. Immunology 9:883-889.
359. Lee, Y. K., and S. K. Mazmanian. 2010. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330:1768-1773.
360. Round, J. L., R. M. O’Connell, and S. K. Mazmanian. 2010. Coordination of tolerogenic immune responses by the commensal microbiota. Journal of Autoimmunity 34:J220-225.
361. Moresco, E. M., D. LaVine, and B. Beutler. 2011. Toll-like receptors. Current Biology 21:R488-493.
362. Fagarasan, S., S. Kawamoto, O. Kanagawa, and K. Suzuki. 2010. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annual Review of Immunology 28:243-273.
363. Kaser, A., and R. S. Blumberg. 2011. Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology 140:1738-1747.
364. Lodes, M. J., Y. Cong, C. O. Elson, R. Mohamath, C. J. Landers, S. R. Targan, M. Fort, and R. M. Hershberg. 2004. Bacterial flagellin is a dominant antigen in Crohn disease. Journal of Clinical Investigation 113:1296-1306.
365. Loftus, E. V., Jr. 2004. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126:1504-1517.
366. Shapira, Y., N. Agmon-Levin, and Y. Shoenfeld. 2010. Defining and analyzing geoepidemiology and human autoimmunity. Journal of Autoimmunity 34:J168-177.
367. Sonneberg, A., and I. H. Wasseman. 1991. Epidemiology of inflammatory bowel diseases among U.S. military veterans. Gastroenterology 101:122-130.
368. Ardizzone, S., A. Cassinotti, M. Bevilacqua, M. Clerici, and G. B. Porro. 2011. Vitamin D and inflammatory bowel disease. Vitamins and Hormones 86:367-377.
369. Cross, H. S., T. Nittke, and E. Kallay. 2011. Colonic vitamin D metabolism: Implications for the pathogenesis of inflammatory bowel disease and colorectal cancer. Molecular and Cellular Endocrinology 347:70-79.
370. Mascitelli, L., F. Pezzetta, and M. R. Goldstein. 2011. Inflammatory bowel disease and the vitamin D endocrine system. Internal Medicine Journal 41:369-370.
371. Raman, M., A. N. Milestone, J. R. Walters, A. L. Hart, and S. Ghosh. 2011. Vitamin D and gastrointestinal diseases: Inflammatory bowel disease and colorectal cancer. Therapeutic Advances in Gastroenterology 4:49-62.
372. Mikulecky, M., and I. Cierna. 2005. Seasonality of births and childhood inflammatory bowel disease. Wiener Klinische Wochenschrift 117:554-557.
373. Chowers, Y., S. Odes, Y. Bujanover, R. Eliakim, S. Bar Meir, and B. Avidan. 2004. The month of birth is linked to the risk of Crohn’s disease in the Israeli population. The American Journal of Gastroenterology 99:1974-1976.
374. Van Ranst, M., M. Joossens, S. Joossens, K. Van Steen, M. Pierik, S. Vermeire, and P. Rutgeerts. 2005. Crohn’s disease and month of birth. Inflammatory Bowel Diseases 11:597-599.
375. Angelucci, E., A. Cocco, M. Cesarini, A. Crudeli, S. Necozione, R. Caprilli, and G. Latella. 2009. Monthly and seasonal birth patterns and the occurrence of Crohn’s disease. The American Journal of Gastroenterology 104:1608-1609.
376. Romberg-Camps, M. J., M. A. Hesselink-van de Kruijs, L. J. Schouten, P. C. Dagnelie, C. B. Limonard, A. D. Kester, L. P. Bos, J. Goedhard, W. H. Hameeteman, F. L. Wolters, M. G. Russel, and R. W. Stockbrugger. 2009. Inflammatory bowel disease in south limburg (the Netherlands) 1991-2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms. Journal of Crohn’s & Colitis 3:115-124.
377. Sonnenberg, A. 2009. Date of birth in the occurrence of inflammatory bowel disease. Inflammatory Bowel Diseases 15:206-211.
378. Zeng, L., and F. H. Anderson. 1996. Seasonal change in the exacerbations of Crohn’s disease. Scandinavian Journal of Gastroenterology 31:79-82.
379. Aratari, A., C. Papi, B. Galletti, E. Angelucci, A. Viscido, V. D’Ovidio, A. Ciaco, M. Abdullahi, and R. Caprilli. 2006. Seasonal variations in onset of symptoms in Crohn’s disease. Digestive and Liver Disease 38:319-323.
380. Bai, A., Y. Guo, Y. Shen, Y. Xie, X. Zhu, and N. Lu. 2009. Seasonality in flares and months of births of patients with ulcerative colitis in a Chinese population. Digestive Diseases and Sciences 54:1094-1098.
381. Lewis, J. D., F. N. Aberra, G. R. Lichtenstein, W. B. Bilker, C. Brensinger, and B. L. Strom. 2004. Seasonal variation in flares of inflammatory bowel disease. Gastroenterology 126:665-673.
382. Garland, C. F., and F. C. Garland. 1980. Do sunlight and vitamin D reduce the likelihood of colon cancer? International Journal of Epidemiology 9:227-231.
383. Sonnenberg, A. 1990. Occupational distribution of inflammatory bowel disease among German employees. Gut 31:1037-1040.
384. Nerich, V., P. Jantchou, M. C. Boutron-Ruault, E. Monnet, A. Weill, V. Vanbockstael, G. R. Auleley, C. Balaire, P. Dubost, S. Rican, H. Allemand, and F. Carbonnel. 2011. Low exposure to sunlight is a risk factor for Crohn’s disease. Alimentary Pharmacology & Therapeutics 33:940-945.
385. Khalili, H., E. S. Huang, A. N. Ananthakrishnan, L. Higuchi, J. M. Richter, C. S. Fuchs, and A. T. Chan. 2012. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 10.1136/gutjnl-2011-301574.
386. Cross, H. S., P. Bareis, H. Hofer, M. G. Bischof, E. Bajna, S. Kriwanek, E. Bonner, and M. Peterlik. 2001. 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66:287-292.
387. Kallay, E., P. Pietschmann, S. Toyokuni, E. Bajna, P. Hahn, K. Mazzucco, C. Bieglmayer, S. Kato, and H. S. Cross. 2001. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22:1429-1435.
388. Cantorna, M. T., C. Munsick, C. Bemiss, and B. D. Mahon. 2000. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. Journal of Nutrition 130:2648-2652.
389. Pappa, H. M., R. J. Grand, and C. M. Gordon. 2006. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflammatory Bowel Diseases 12:1162-1174.
390. Leslie, W. D., N. Miller, L. Rogala, and C. N. Bernstein. 2008. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: The Manitoba IBD Cohort Study. The American Journal of Gastroenterology 103:1451-1459.
391. Levin, A. D., V. Wadhera, S. T. Leach, H. J. Woodhead, D. A. Lemberg, A. C. Mendoza-Cruz, and A. S. Day. 2011. Vitamin D deficiency in children with inflammatory bowel disease. Digestive Diseases and Sciences 56:830-836.
392. Bowden, S. A., R. F. Robinson, R. Carr, and J. D. Mahan. 2008. Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic. Pediatrics 121:e1585-1590.
393. Gilman, J., F. Shanahan, and K. D. Cashman. 2006. Determinants of vitamin D status in adult Crohn’s disease patients, with particular emphasis on supplemental vitamin D use. European Journal of Clinical Nutrition 60:889-896.
394. El-Matary, W., S. Sikora, and D. Spady. 2011. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Digestive Diseases and Sciences 56:825-829.
395. Pappa, H. M., E. J. Langereis, R. J. Grand, and C. M. Gordon. 2011. Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease: A retrospective study. Journal of Pediatric Gastroenterology and Nutrition 53:361-364.
396. Atia, A., R. Murthy, B. A. Bailey, T. Manning, L. L. Garrett, D. Youssef, and A. N. Peiris. 2011. Vitamin D status in veterans with inflammatory bowel disease: Relationship to health care costs and services. Military Medicine 176:711-714.
397. Ulitsky, A., A. N. Ananthakrishnan, A. Naik, S. Skaros, Y. Zadvornova, D. G. Binion, and M. Issa. 2011. Vitamin D deficiency in patients with inflammatory bowel disease: Association with disease activity and quality of life. JPEN. Journal of Parenteral and Enteral Nutrition 35:308-316.
398. Bours, P. H., J. P. Wielders, J. R. Vermeijden, and A. van de Wiel. 2010. Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease. Osteoporosis International 22:2857-2867.
399. Joseph, A. J., B. George, A. B. Pulimood, M. S. Seshadri, and A. Chacko. 2009. 25 (OH) vitamin D level in Crohn’s disease: Association with sun exposure and disease activity. The Indian Journal of Medical Research 130:133-137.
400. Tajika, M., A. Matsuura, T. Nakamura, T. Suzuki, A. Sawaki, T. Kato, K. Hara, K. Ookubo, K. Yamao, M. Kato, and Y. Muto. 2004. Risk factors for vitamin D deficiency in patients with Crohn’s disease. Journal of Gastroenterology 39:527-533.
401. Van Limbergen, J., R. K. Russell, E. R. Nimmo, and J. Satsangi. 2007. The genetics of inflammatory bowel disease. The American Journal of Gastroenterology 102:2820-2831.
402. Kanneganti, T. D., M. Lamkanfi, and G. Nunez. 2007. Intracellular NOD-like receptors in host defense and disease. Immunity 27:549-559.
403. Baranzini, S. E., N. W. Galwey, J. Wang, P. Khankhanian, R. Lindberg, D. Pelletier, W. Wu, B. M. Uitdehaag, L. Kappos, C. H. Polman, P. M. Matthews, S. L. Hauser, R. A. Gibson, J. R. Oksenberg, and M. R. Barnes. 2009. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Human Molecular Genetics 18:2078-2090.
404. Rubtsov, Y. P., J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson, Jr., W. Muller, and A. Y. Rudensky. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28:546-558.
405. Cyktor, J. C., and J. Turner. 2011. Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infection and Immunity 79:2964-2973.
406. Wang, T. T., B. Dabbas, D. Laperriere, A. J. Bitton, H. Soualhine, L. E. Tavera-Mendoza, S. Dionne, M. J. Servant, A. Bitton, E. G. Seidman, S. Mader, M. A. Behr, and J. H. White. 2010. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. Journal of Biological Chemistry 285:2227-2231.
407. Chen, S., G. P. Sims, X. X. Chen, Y. Y. Gu, and P. E. Lipsky. 2007. Modulatory effects of 1,25-Dihydroxyvitamin D3 on human B cell differentiation. Journal of Immunology 179:1634-1647.
408. Heine, G., U. Niesner, H. D. Chang, A. Steinmeyer, U. Zugel, T. Zuberbier, A. Radbruch, and M. Worm. 2008. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. European Journal of Immunology 38:2210-2218.
409. Wang, K., R. Baldassano, H. Zhang, H. Q. Qu, M. Imielinski, S. Kugathasan, V. Annese, M. Dubinsky, J. I. Rotter, R. K. Russell, J. P. Bradfield, P. M. Sleiman, J. T. Glessner, T. Walters, C. Hou, C. Kim, E. C. Frackelton, M. Garris, J. Doran, C. Romano, C. Catassi, J. Van Limbergen, S. L. Guthery, L. Denson, D. Piccoli, M. S. Silverberg, C. A. Stanley, D. Monos, D. C. Wilson, A. Griffiths, S. F. Grant, J. Satsangi, C. Polychronakos, and H. Hakonarson. 2010. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Human Molecular Genetics 19:2059-2067.
410. Simmons, J. D., C. Mullighan, K. I. Welsh, and D. P. Jewell. 2000. Vitamin D receptor gene polymorphism: Association with Crohn’s disease susceptibility. Gut 47:211-214.
411. Naderi, N., A. Farnood, M. Habibi, F. Derakhshan, H. Balaii, Z. Motahari, M. R. Agah, F. Firouzi, M. G. Rad, R. Aghazadeh, H. Zojaji, and M. R. Zali. 2008. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology 23:1816-1822.
412. Pei, F. H., Y. J. Wang, S. L. Gao, B. R. Liu, Y. J. Du, W. Liu, H. Y. Yu, L. X. Zhao, and B. R. Chi. 2011. Vitamin D receptor gene polymorphism and ulcerative colitis susceptibility in Han Chinese. Journal of Digestive Diseases 12:90-98.
413. Dresner-Pollak, R., Z. Ackerman, R. Eliakim, A. Karban, Y. Chowers, and H. H. Fidder. 2004. The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients. Genetic Testing 8:417-420.
414. Eloranta, J. J., C. Wenger, J. Mwinyi, C. Hiller, C. Gubler, S. R. Vavricka, M. Fried, and G. A. Kullak-Ublick. 2011. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenetics and Genomics 21:559-564.
415. Nagasawa, H., Y. Uto, H. Sasaki, N. Okamura, A. Murakami, S. Kubo, K. L. Kirk, and H. Hori. 2005. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Research 25:3689-3695.
416. Miheller, P., G. Muzes, I. Hritz, G. Lakatos, I. Pregun, P. L. Lakatos, L. Herszenyi, and Z. Tulassay. 2009. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn’s disease patients. Inflammatory Bowel Diseases 15:1656-1662.
417. Jorgensen, S. P., J. Agnholt, H. Glerup, S. Lyhne, G. E. Villadsen, C. L. Hvas, L. E. Bartels, J. Kelsen, L. A. Christensen, and J. F. Dahlerup. 2010. Clinical trial: Vitamin D3 treatment in Crohn’s disease-a randomized double-blind placebo-controlled study. Alimentary Pharmacology & Therapeutics 32:377-383.
418. Hollis, B. W. 2005. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. Journal of Nutrition 135:317-322.
419. Saleh, M., and C. O. Elson. 2011. Experimental inflammatory bowel disease: Insights into the host-microbiota dialog. Immunity 34:293-302.
420. Mizoguchi, A., and E. Mizoguchi. 2010. Animal models of IBD: Linkage to human disease. Current Opinion in Pharmacology 10:578-587.
421. Froicu, M., and M. T. Cantorna. 2007. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunology 8:5.
422. Laverny, G., G. Penna, S. Vetrano, C. Correale, M. Nebuloni, S. Danese, and L. Adorini. 2010. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunology Letters 131:49-58.
423. Liu, N., L. Nguyen, R. F. Chun, V. Lagishetty, S. Ren, S. Wu, B. Hollis, H. F. DeLuca, J. S. Adams, and M. Hewison. 2008. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 149:4799-4808.
424. Froicu, M., V. Weaver, T. A. Wynn, M. A. McDowell, J. E. Welsh, and M. T. Cantorna. 2003. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Molecular Endocrinology 17:2386-2392.
425. Kong, J., Z. Zhang, M. W. Musch, G. Ning, J. Sun, J. Hart, M. Bissonnette, and Y. C. Li. 2008. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. American Journal of Physiology. Gastrointestinal and Liver Physiology 294:G208-216.
426. Hewison, M. 2011. Antibacterial effects of vitamin D. Nature Reviews. Endocrinology 7:337-345.
427. van Heel, D. A., S. Ghosh, M. Butler, K. A. Hunt, A. M. Lundberg, T. Ahmad, D. P. McGovern, C. Onnie, K. Negoro, S. Goldthorpe, B. M. Foxwell, C. G. Mathew, A. Forbes, D. P. Jewell, and R. J. Playford. 2005. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn’s disease. Lancet 365:1794-1796.
428. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, D. L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zugel, R. L. Gallo, D. Eisenberg, M. Hewison, B. W. Hollis, J. S. Adams, B. R. Bloom, and R. L. Modlin. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773.
429. Krutzik, S. R., M. Hewison, P. T. Liu, J. A. Robles, S. Stenger, J. S. Adams, and R. L. Modlin. 2008. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. Journal of Immunology 181:7115-7120.
430. Wang, T. T., F. P. Nestel, V. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L. Tavera-Mendoza, R. Lin, J. W. Hanrahan, S. Mader, and J. H. White. 2004. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of Immunology 173:2909-2912.
431. Weber, G., J. D. Heilborn, C. I. Chamorro Jimenez, A. Hammarsjo, H. Torma, and M. Stahle. 2005. Vitamin D induces the antimicrobial protein hCAP18 in human skin. The Journal of Investigative Dermatology 124:1080-1082.
432. Gombart, A. F., N. Borregaard, and H. P. Koeffler. 2005. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB Journal 19:1067-1077.
433. Sadeghi, K., B. Wessner, U. Laggner, M. Ploder, D. Tamandl, J. Friedl, U. Zugel, A. Steinmeyer, A. Pollak, E. Roth, G. Boltz-Nitulescu, and A. Spittler. 2006. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. European Journal of Immunology 36:361-370.
434. Verway, M., M. A. Behr, and J. H. White. 2010. Vitamin D, NOD2, autophagy and Crohn’s disease. Expert Review of Clinical Immunology 6:505-508.
435. Gombart, A. F., T. Saito, and H. P. Koeffler. 2009. Exapation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics 10:321.
436. Lagishetty, V., A. V. Misharin, N. Q. Liu, T. S. Lisse, R. F. Chun, Y. Ouyang, S. M. McLachlan, J. S. Adams, and M. Hewison. 2010. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151:2423-2432.
437. Taniguchi, M., K. Seino, and T. Nakayama. 2003. The NKT cell system: Bridging innate and acquired immunity. Nature Immunology 4:1164-1165.
438. Yu, S., and M. T. Cantorna. 2008. The vitamin D receptor is required for iNKT cell development. Proceedings of the National Academy of Sciences of the United States of America 105:5207-5212.
439. Strober, W., I. Fuss, and P. Mannon. 2007. The fundamental basis of inflammatory bowel disease. Journal of Clinical Investigation 117:514-521.
440. Sarra, M., F. Pallone, T. T. Macdonald, and G. Monteleone. 2010. IL-23/IL-17 axis in IBD. Inflammatory Bowel Diseases 16:1808-1813.
441. Shen, W., and S. K. Durum. 2010. Synergy of IL-23 and Th17 cytokines: New light on inflammatory bowel disease. Neurochemical Research 35:940-946.
442. Bruce, D., S. Yu, J. H. Ooi, and M. T. Cantorna. 2011. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. International Immunology 23:519-528.
443. Thompson, A. I., and C. W. Lees. 2011. Genetics of ulcerative colitis. Inflammatory Bowel Diseases 17:831-848.
444. Bartels, L. E., S. P. Jorgensen, J. Agnholt, J. Kelsen, C. L. Hvas, and J. F. Dahlerup. 2007. 1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn’s disease. International Immunopharmacology 7:1755-1764.
445. Urry, Z., E. Xystrakis, D. F. Richards, J. McDonald, Z. Sattar, D. J. Cousins, C. J. Corrigan, E. Hickman, Z. Brown, and C. M. Hawrylowicz. 2009. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. Journal of Clinical Investigation 119:387-398.
446. Biggs, L., C. Yu, B. Fedoric, A. F. Lopez, S. J. Galli, and M. A. Grimbaldeston. 2010. Evidence that vitamin D(3) promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice. Journal of Experimental Medicine 207:455-463.
447. Yu, S., D. Bruce, M. Froicu, V. Weaver, and M. T. Cantorna. 2008. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proceedings of the National Academy of Sciences of the United States of America 105:20834-20839.
448. Bruce, D., and M. T. Cantorna. 2011. Intrinsic requirement for the vitamin D receptor in the development of CD8alphaalpha-expressing T cells. Journal of Immunology 186:2819-2825.
449. Protiva, P., H. S. Cross, M. E. Hopkins, E. Kallay, G. Bises, E. Dreyhaupt, L. Augenlicht, M. Lipkin, M. Lesser, E. Livote, and P. R. Holt. 2009. Chemoprevention of colorectal neoplasia by estrogen: Potential role of vitamin D activity. Cancer Prevention Research (Philadelphia, Pa.) 2:43-51.
450. Tsokos, G. C. 2011. Systemic lupus erythematosus. New England Journal of Medicine 365:2110-2121.
451. Flesher, D. L., X. Sun, T. W. Behrens, R. R. Graham, and L. A. Criswell. 2010. Recent advances in the genetics of systemic lupus erythematosus. Expert Review of Clinical Immunology 6:461-479.
452. Grennan, D. M., A. Parfitt, N. Manolios, Q. Huang, V. Hyland, H. Dunckley, T. Doran, P. Gatenby, and C. Badcock. 1997. Family and twin studies in systemic lupus erythematosus. Disease Markers 13:93-98.
453. Sanders, C. J., H. Van Weelden, G. A. Kazzaz, V. Sigurdsson, J. Toonstra, and C. A. Bruijnzeel-Koomen. 2003. Photosensitivity in patients with lupus erythematosus: A clinical and photobiological study of 100 patients using a prolonged phototest protocol. The British Journal of Dermatology 149:131-137.
454. Meller, S., F. Winterberg, M. Gilliet, A. Muller, I. Lauceviciute, J. Rieker, N. J. Neumann, R. Kubitza, M. Gombert, E. Bunemann, U. Wiesner, P. Franken-Kunkel, H. Kanzler, M. C. Dieu-Nosjean, A. Amara, T. Ruzicka, P. Lehmann, A. Zlotnik, and B. Homey. 2005. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis and Rheumatism 52:1504-1516.
455. Bijl, M., and C. G. Kallenberg. 2006. Ultraviolet light and cutaneous lupus. Lupus 15:724-727.
456. Kuhn, A., M. Herrmann, S. Kleber, M. Beckmann-Welle, K. Fehsel, A. Martin-Villalba, P. Lehmann, T. Ruzicka, P. H. Krammer, and V. Kolb-Bachofen. 2006. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis and Rheumatism 54:939-950.
457. Breslin, L. C., P. J. Magee, J. M. Wallace, and E. M. McSorley. 2011. An evaluation of vitamin D status in individuals with systemic lupus erythematosus. The Proceedings of the Nutrition Society 70:399-407.
458. Holick, M. F. 2008. Sunlight, UV-radiation, vitamin D and skin cancer: How much sunlight do we need? Advances in Experimental Medicine and Biology 624:1-15.
459. Kamen, D. L. 2010. Vitamin D in lupus-new kid on the block? Bulletin of the NYU Hospital for Joint Diseases 68:218-222.
460. Cutolo, M., M. Plebani, Y. Shoenfeld, L. Adorini, and A. Tincani. 2011. Vitamin D endocrine system and the immune response in rheumatic diseases. Vitamins and Hormones 86:327-351.
461. Zandman-Goddard, G., M. Solomon, Z. Rosman, E. Peeva, and Y. Shoenfeld. 2012. Environment and lupus-related diseases. Lupus 21:241-250.
462. Somers, E. C., S. L. Thomas, L. Smeeth, W. M. Schoonen, and A. J. Hall. 2007. Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. Arthritis and Rheumatism 57:612-618.
463. Walsh, S. J., and L. M. DeChello. 2001. Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus 10:637-646.
464. Grant, W. B. 2004. Solar UV-B radiation is linked to the geographic variation of mortality from systemic lupus erythematosus in the USA. Lupus 13:281-282.
465. Walsh, S. J., and A. Gilchrist. 2006. Geographical clustering of mortality from systemic lupus erythematosus in the United States: Contributions of poverty, Hispanic ethnicity and solar radiation. Lupus 15:662-670.
466. Haga, H. J., J. G. Brun, O. P. Rekvig, and L. Wetterberg. 1999. Seasonal variations in activity of systemic lupus erythematosus in a subarctic region. Lupus 8:269-273.
467. Costenbader, K. H., D. Feskanich, M. Holmes, E. W. Karlson, and E. Benito-Garcia. 2008. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Annals of the Rheumatic Diseases 67:530-535.
468. Kamen, D. L., G. S. Cooper, H. Bouali, S. R. Shaftman, B. W. Hollis, and G. S. Gilkeson. 2006. Vitamin D deficiency in systemic lupus erythematosus. Autoimmunity Reviews 5:114-117.
469. Wright, T. B., J. Shults, M. B. Leonard, B. S. Zemel, and J. M. Burnham. 2009. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. Journal of Pediatrics 155:260-265.
470. Borba, V. Z., J. G. Vieira, T. Kasamatsu, S. C. Radominski, E. I. Sato, and M. Lazaretti-Castro. 2009. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporosis International 20:427-433.
471. Thudi, A., S. Yin, A. E. Wandstrat, Q. Z. Li, and N. J. Olsen. 2008. Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. The American Journal of the Medical Sciences 335:99-104.
472. Ruiz-Irastorza, G., M. V. Egurbide, N. Olivares, A. Martinez-Berriotxoa, and C. Aguirre. 2008. Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology (Oxford) 47:920-923.
473. Chen, S., G. P. Sims, X. X. Chen, Y. Y. Gu, and P. E. Lipsky. 2007. Modulatory effects of 1,25-Dihydroxyvitamin D3 on human B cell differentiation. Journal of Immunology 179:1634-1647.
474. Damanhouri, L. H. 2009. Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Medical Journal 30:1291-1295.
475. Wu, P. W., E. Y. Rhew, A. R. Dyer, D. D. Dunlop, C. B. Langman, H. Price, K. Sutton-Tyrrell, D. D. McPherson, D. Edmundowicz, G. T. Kondos, and R. Ramsey-Goldman. 2009. 25-Hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis and Rheumatism 61:1387-1395.
476. Bogaczewicz, J., A. Sysa-Jedrzejowska, C. Arkuszewska, J. Zabek, E. Kontny, D. P. McCauliffe, and A. Wozniacka. 2011. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 21:477-484.
477. Amital, H., Z. Szekanecz, G. Szucs, K. Danko, E. Nagy, T. Csepany, E. Kiss, J. Rovensky, A. Tuchynova, D. Kozakova, A. Doria, N. Corocher, N. Agmon-Levin, V. Barak, H. Orbach, G. Zandman-Goddard, and Y. Shoenfeld. 2010. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D? Annals of the Rheumatic Diseases 69:1155-1157.
478. Ben-Zvi, I., C. Aranow, M. Mackay, A. Stanevsky, D. L. Kamen, L. M. Marinescu, C. E. Collins, G. S. Gilkeson, B. Diamond, and J. A. Hardin. 2010. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 5:e9193.
479. Hamza, R. T., K. S. Awwad, M. K. Ali, and A. I. Hamed. 2011. Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: Relation to disease activity. Medical Science Monitor 17:CR711-718.
480. Reynolds, J. A., S. Haque, J. L. Berry, P. Pemberton, L. S. Teh, P. Ho, R. Gorodkin, and I. N. Bruce. 2011. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford) 51:544-551.
481. Szodoray, P., T. Tarr, A. Bazso, G. Poor, G. Szegedi, and E. Kiss. 2011. The immunopathological role of vitamin D in patients with SLE: Data from a single centre registry in Hungary. Scandinavian Journal of Rheumatology 40:122-126.
482. Word, A. P., F. Perese, L. C. Tseng, B. Adams-Huet, N. J. Olsen, and B. F. Chong. 2012. 25-Hydroxyvitamin D levels in African-American and Caucasian/Hispanic subjects with cutaneous lupus erythematosus. The British Journal of Dermatology 166:372-379.
483. Mok, C. C., D. J. Birmingham, H. W. Leung, L. A. Hebert, H. Song, and B. H. Rovin. 2011. Vitamin D levels in Chinese patients with systemic lupus erythematosus: Relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) 51:644-652.
484. Mok, C. C., D. J. Birmingham, L. Y. Ho, L. A. Hebert, H. Song, and B. H. Rovin. 2012. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: A comparison with anti-dsDNA and anti-C1q. Lupus 21:36-42.
485. Bonakdar, Z. S., L. Jahanshahifar, F. Jahanshahifar, and A. Gholamrezaei. 2011. Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 20:1155-1160.
486. Lopez-Robles, C., R. Rios-Fernandez, J. L. Callejas-Rubio, and N. Ortego-Centeno. 2011. Vitamin D deficiency in a cohort of patients with systemic lupus erythematous from the South of Spain. Lupus 20:330-331.
487. Ruiz-Irastorza, G., S. Gordo, N. Olivares, M. V. Egurbide, and C. Aguirre. 2010. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care & Research 62:1160-1165.
488. Toloza, S. M., D. E. Cole, D. D. Gladman, D. Ibanez, and M. B. Urowitz. 2010. Vitamin D insufficiency in a large female SLE cohort. Lupus 19:13-19.
489. Robinson, A. B., M. Thierry-Palmer, K. L. Gibson, and C. E. Rabinovich. 2012. Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis. Journal of Pediatrics 160:297-302.
490. Ritterhouse, L. L., S. R. Crowe, T. B. Niewold, D. L. Kamen, S. R. Macwana, V. C. Roberts, A. B. Dedeke, J. B. Harley, R. H. Scofield, J. M. Guthridge, and J. A. James. 2011. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases 70:1569-1574.
491. Lee, Y. H., S. C. Bae, S. J. Choi, J. D. Ji, and G. G. Song. 2011. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: A meta-analysis. Molecular Biology Reports 38:3643-3651.
492. Luo, X. Y., M. H. Yang, F. X. Wu, L. J. Wu, L. Chen, Z. Tang, N. T. Liu, X. F. Zeng, J. L. Guan, and G. H. Yuan. 2012. Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 21:53-59.
493. Abbasi, M., Z. Rezaieyazdi, J. T. Afshari, M. Hatef, M. Sahebari, and N. Saadati. 2010. Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus. Rheumatology International 30:1537-1539.
494. Monticielo, O. A., J. C. Brenol, J. A. Chies, M. G. Longo, G. G. Rucatti, R. Scalco, and R. M. Xavier. 2012. The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 21:43-52.
495. Fernando, M. M., C. R. Stevens, P. C. Sabeti, E. C. Walsh, A. J. McWhinnie, A. Shah, T. Green, J. D. Rioux, and T. J. Vyse. 2007. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genetics 3:e192.
496. Furukawa, F., Y. Yamamoto, N. Kanazawa, and M. Muto. 2009. Race differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus from the aspect of Japanese studies. Annals of the New York Academy of Sciences 1173:552-556.
497. Furukawa, F., and M. Muto. 2009. Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus. Archives of Dermatological Research 301:111-115.
498. Ramagopalan, S. V., J. Link, J. K. Byrnes, D. A. Dyment, G. Giovannoni, R. Q. Hintzen, E. Sundqvist, I. Kockum, C. Smestad, B. A. Lie, H. F. Harbo, L. Padyukov, L. Alfredsson, T. Olsson, A. D. Sadovnick, J. Hillert, and G. C. Ebers. 2009. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 73:2107-2111.
499. Fairhurst, A. M., A. E. Wandstrat, and E. K. Wakeland. 2006. Systemic lupus erythematosus: Multiple immunological phenotypes in a complex genetic disease. Advances in Immunology 92:1-69.
500. Perry, D., A. Sang, Y. Yin, Y. Y. Zheng, and L. Morel. 2011. Murine models of systemic lupus erythematosus. Journal of Biomedicine & Biotechnology 2011:271694.
501. Gulinello, M., and C. Putterman. 2011. The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. Journal of Biomedicine & Biotechnology 2011:207504.
502. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annual Review of Immunology 9:243-269.
503. Zhang, Z., V. C. Kyttaris, and G. C. Tsokos. 2009. The role of IL-23/IL-17 axis in lupus nephritis. Journal of Immunology 183:3160-3169.
504. Lemire, J. M., A. Ince, and M. Takashima. 1992. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice. Autoimmunity 12:143-148.
505. Deluca, H. F., and M. T. Cantorna. 2001. Vitamin D: Its role and uses in immunology. FASEB Journal 15:2579-2585.
506. Grimbaldeston, M. A., S. Nakae, J. Kalesnikoff, M. Tsai, and S. J. Galli. 2007. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nature Immunology 8:1095-1104.
507. Lerman, M., J. Burnham, and E. Behrens. 2011. 1,25 Dihydroxyvitamin D3 limits monocyte maturation in lupus sera. Lupus 20:749-753.
508. Wong, C. K., L. C. Lit, L. S. Tam, E. K. Li, P. T. Wong, and C. W. Lam. 2008. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity. Clinical Immunology 127:385-393.
509. Crispin, J. C., M. Oukka, G. Bayliss, R. A. Cohen, C. A. Van Beek, I. E. Stillman, V. C. Kyttaris, Y. T. Juang, and G. C. Tsokos. 2008. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. Journal of Immunology 181:8761-8766.
510. Mok, M. Y., H. J. Wu, Y. Lo, and C. S. Lau. 2010. The relation of interleukin 17 (IL-17) and IL-23 to Th1/Th2 cytokines and disease activity in systemic lupus erythematosus. The Journal of Rheumatology 37:2046-2052.
511. Tanasescu, C., E. Balanescu, P. Balanescu, R. Olteanu, C. Badea, C. Grancea, C. Vagu, C. Bleotu, C. Ardeleanu, and A. Georgescu. 2010. IL-17 in cutaneous lupus erythematosus. European Journal of Internal Medicine 21:202-207.
512. Crispin, J. C., and G. C. Tsokos. 2010. IL-17 in systemic lupus erythematosus. Journal of Biomedicine & Biotechnology 2010:943254.
513. Apostolidis, S. A., J. C. Crispin, and G. C. Tsokos. 2011. IL-17-producing T cells in lupus nephritis. Lupus 20:120-124.
514. Perry, D., A. B. Peck, W. C. Carcamo, L. Morel, and C. Q. Nguyen. 2011. The current concept of T(h)17 cells and their expanding role in systemic lupus erythematosus. Arthritis 2011:810649.
515. Cutolo, M., C. Pizzorni, and A. Sulli. 2011. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmunity Reviews 11:84-87.
516. Marques, C. D., A. T. Dantas, T. S. Fragoso, and A. L. Duarte. 2010. The importance of vitamin D levels in autoimmune diseases. Revista Brasileira de Reumatologia 50:67-80.
517. Wen, H., and J. F. Baker. 2011. Vitamin D, immunoregulation, and rheumatoid arthritis. Journal of Clinical Rheumatology 17:102-107.
518. Tran, C. N., S. K. Lundy, and D. A. Fox. 2005. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 12:183-189.
519. Karouzakis, E., M. Neidhart, R. E. Gay, and S. Gay. 2006. Molecular and cellular basis of rheumatoid joint destruction. Immunology Letters 106:8-13.
520. Lundy, S. K., S. Sarkar, L. A. Tesmer, and D. A. Fox. 2007. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Research & Therapy 9:202.
521. Merlino, L. A., J. Curtis, T. R. Mikuls, J. R. Cerhan, L. A. Criswell, and K. G. Saag. 2004. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women’s Health Study. Arthritis and Rheumatism 50:72-77.
522. Nielen, M. M., D. van Schaardenburg, W. F. Lems, R. J. van de Stadt, M. H. de Koning, H. W. Reesink, M. R. Habibuw, I. E. van der Horst-Bruinsma, J. W. Twisk, and B. A. Dijkmans. 2006. Vitamin D deficiency does not increase the risk of rheumatoid arthritis: Comment on the article by Merlino et al. Arthritis and Rheumatism 54:3719-3720.
523. Als, O. S., B. Riis, and C. Christiansen. 1987. Serum concentration of vitamin D metabolites in rheumatoid arthritis. Clinical Rheumatology 6:238-243.
524. Craig, S. M., F. Yu, J. R. Curtis, G. S. Alarcon, D. L. Conn, B. Jonas, L. F. Callahan, E. A. Smith, L. W. Moreland, S. L. Bridges, Jr., and T. R. Mikuls. 2010. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. The Journal of Rheumatology 37:275-281.
525. Kerr, G. S., I. Sabahi, J. S. Richards, L. Caplan, G. W. Cannon, A. Reimold, G. M. Thiele, D. Johnson, and T. R. Mikuls. 2011. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. The Journal of Rheumatology 38:53-59.
526. Kroger, H., I. M. Penttila, and E. M. Alhava. 1993. Low serum vitamin D metabolites in women with rheumatoid arthritis. Scandinavian Journal of Rheumatology 22:172-177.
527. Heidari, B., K. Hajian-Tilaki, and P. Heidari. 2012. The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls. Rheumatology International 32:991-995.
528. Rossini, M., S. Maddali Bongi, G. La Montagna, G. Minisola, N. Malavolta, L. Bernini, E. Cacace, L. Sinigaglia, O. Di Munno, and S. Adami. 2010. Vitamin D deficiency in rheumatoid arthritis: Prevalence, determinants and associations with disease activity and disability. Arthritis Research & Therapy 12:R216.
529. Turhanoglu, A. D., H. Guler, Z. Yonden, F. Aslan, A. Mansuroglu, and C. Ozer. 2010. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatology International 31:911-914.
530. Cutolo, M., K. Otsa, K. Laas, M. Yprus, R. Lehtme, M. E. Secchi, A. Sulli, S. Paolino, and B. Seriolo. 2006. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus southern Europe. Clinical and Experimental Rheumatology 24:702-704.
531. Haque, U. J., and S. J. Bartlett. 2010. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clinical and Experimental Rheumatology 28:745-747.
532. Patel, S., T. Farragher, J. Berry, D. Bunn, A. Silman, and D. Symmons. 2007. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis and Rheumatism 56:2143-2149.
533. Gonzalez, M. P., Z. Gandara, Y. Fall, and G. Gomez. 2008. Radial distribution function descriptors for predicting affinity for vitamin D receptor. European Journal of Medicinal Chemistry 43:1360-1365.
534. Karray, E. F., I. Ben Dhifallah, K. Ben Abdelghani, I. Ben Ghorbel, M. Khanfir, H. Houman, K. Hamzaoui, and L. Zakraoui. 2012. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behcet’s disease in Tunisians. Joint Bone Spine 79:144-148.
535. Maalej, A., E. Petit-Teixeira, L. Michou, A. Rebai, F. Cornelis, and H. Ayadi. 2005. Association study of VDR gene with rheumatoid arthritis in the French population. Genes and Immunity 6:707-711.
536. Milchert, M. 2010. [Association between BsmI vitamin D receptor gene polymorphism and serum concentration of vitamin D with progression of rheumatoid arthritis]. Annales Academiae Medicae Stetinensis 56:45-56.
537. Rass, P., A. Pakozdi, P. Lakatos, E. Zilahi, S. Sipka, G. Szegedi, and Z. Szekanecz. 2006. Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatology International 26:964-971.
538. Andjelkovic, Z., J. Vojinovic, N. Pejnovic, M. Popovic, A. Dujic, D. Mitrovic, L. Pavlica, and D. Stefanovic. 1999. Disease modifying and immunomodulatory effects of high dose 1 alpha(OH)D3 in rheumatoid arthritis patients. Clinical and Experimental Rheumatology 17:453-456.
539. Gopinath, K., and D. Danda. 2011. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: A randomized controlled trial. International Journal of Rheumatic Diseases 14:332-339.
540. Salesi, M., and Z. Farajzadegan. 2012. Efficacy of vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatology International 32:2129-2133.
541. Tsuji, M., K. Fujii, T. Nakano, and Y. Nishii. 1994. 1 alpha-Hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats. FEBS Letters 337:248-250.
542. Cantorna, M. T., C. E. Hayes, and H. F. DeLuca. 1998. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. Journal of Nutrition 128:68-72.
543. Moghaddami, M., G. Mayrhofer, P. H. Anderson, H. A. Morris, M. Van Der Hoek, and L. G. Cleland. 2012. Efficacy and mechanisms of action of vitamin D in experimental polyarthritis. Immunology and Cell Biology 90:168-177.
544. Provvedini, D. M., C. D. Tsoukas, L. J. Deftos, and S. C. Manolagas. 1983. 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 221:1181-1183.
545. Bhalla, A. K., E. P. Amento, T. L. Clemens, M. F. Holick, and S. M. Krane. 1983. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation. The Journal of Clinical Endocrinology and Metabolism 57:1308-1310.
546. Nyomba, B. L., J. Auwerx, and V. Bormans. 1986. Pancreatic secretion in man with subclinical vitamin D deficiency. Diabetologia 29:34-38.